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Abstract 
 
 
 
MyTH4 and FERM Have Overlapping and Distinct 
Roles in the Function of Myo1, a Class XIV Myosin in 
Tetrahymena thermophila 
 
By 
 
 
Michael Gotesman 
 
 
 
Adviser: Dr. Ray H. Gavin 
 
 
 
 
MyTH4 and FERM are conserved tail domains in myosin classes VII, X, XII, 
XIV, XV and in MyoG. Myo1, a class XIV myosin in Tetrahymena thermophila, 
contains MyTH4 and FERM. Previous studies have shown that Myo1 localizes to 
phagosomes, the cytoskeleton, and the macronucleus, and that phagosome trafficking and 
division of the macronucleus are affected in a MYO1 knockout. To investigate the roles 
for MyTH4 and FERM in the function of Myo1, GFP-tagged MyTH4, FERM, and 
truncated FERM were separately overexpressed in Tetrahymena. Actin antibody 
coprecipitated tubulin, GFP-MyTH4, and GFP-FERM. GFP-MyTH4 and GFP-FERM 
cosedimented with either exogenous microtubules or exogenous F-actin. GFP-MyTH4 
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localized to phagosomes and colocalized with antitubulin to intranuclear microtubules. 
Overexpression of GFP-MyTH4 inhibited the organization of the parallel array of 
intranuclear microtubules that form prior to division of the macronucleus. Cells that 
failed to form the parallel array of microtubules did not advance in nuclear division. 
Overexpression of GFP-MyTH4 did not affect phagosome recycling. Overexpressed 
GFP-FERM localized to phagosomes, cytoskeleton, and intranuclear puncta and did not 
affect division of the macronucleus. Overexpression of truncated GFP-FERM did not 
localize to the cytoskeleton or nucleus and led to the accumulation of phagosomes at the 
membrane recycling site in the posterior of the cell. It is unlikely that the overexpression 
phenotypes are nonspecific effects of GFP.  Localization of GFP-fusions is consistent 
with the localization of full-length Myo1, and overexpression phenotypes mimic the 
knockout phenotype. Furthermore, GFP-MyTH4 from Myo9, another Tetrahymena 
myosin, did not localize in Tetrahymena thermophila. We conclude that MyTH4 and 
FERM have overlapping roles as indicated by the interaction with actin and tubulin. 
However, MyTH4 and FERM appear to have distinct roles in the function of Myo1. 
MyTH4 affects the organization of microtubules involved in macronuclear division, 
whereas FERM affects recycling of phagosomes and is required for localization to the 
cytoskeleton. 
 v 
Acknowledgments 
I would like to thank my mentor, Professor Ray Gavin, for working with me on 
this great project. I believe that we work well together and we have achieved significant 
progress in better understanding how MyTH4 and FERM function in Myo1. I hope that 
this project will lead to a better appreciation of how protein domains function to serve 
proteins and thereby lead to a better understanding of living organisms. Dr. Gavin, is a 
terrific mentor who has created a wonderful environment in his lab to study and grow as a 
researcher. I would also like to acknowledge that during my ten years in the Gavin lab, I 
have learned many important life lessons from my mentor, in terms of day-to-day décor 
and I developed an overall life perspective. I believe that our relationship has blossomed 
from mentor/student, to friends, and now something even more special. The amazing 
microscopy was achieved by Roland Hosein Jr., who has been a much-appreciated asset 
to my development. He has always been kind and helpful in the lab and I greatly 
appreciate it. Many technical lab skills were taught to me by Roland, and Kester Hayes.   
I would like to also thank Brooklyn College, where I earned my undergraduate 
degree and performed my graduate work. Brooklyn College has provided me with a home 
for research and financial support during my graduate education. I would also like to 
thank members of my Examination Committee, Dr. Selwyn Williams for taking me under 
his wings, Dr. Shaneen Singh for helpful discussions about MyTH4 domains, Dr. 
Theodore Muth for many helpful suggestions, and Drs. Chang-Hui Shen and Christina 
King-Smith for agreeing to serve on my committee. I have also had help from 
undergraduates during my graduate work, including the brother of Dr. Jorge Garces who 
cloned the MYO1 gene, Jonathen Garces, Gabriel Lutz, Nalini Seenath and Jesse Flores 
 vi 
and I would like to thank them for laboratory assistance.  I would like to acknowledge 
that I learned much from the faculty and staff at Brooklyn College, including David 
Klein. My parents have constantly supported me, and I would not have been able to 
achieve my success without their love and support. Preliminary reports on this research 
were presented at the 48-50th Annual Meetings of the American Society for Cell Biology, 
and at the 2010 Pennsylvania Muscle Institute Symposia.
 vii 
Table of Contents 
Chapter 1 Myosin Structure and Function     Pages 1-10 
1.1 Discovery of Myosin  
1.2 General Organization of Myosins  
1.3 What are the Different Myosin Homology Tail Domains? 
1.4 MyTH4 Domain 
1.5 FERM Domain 
1.6 What is Known About the Function of MyTH4/ FERM Coupling in 
Myosins? 
1.7 MyTH4 and FERM Domains in Kinesins 
1.8 Myosin in the Nucleus? 
1.9 Myosin Function in Regulating Actin Dynamics 
1.10 Interaction Among Microtubules and Actin-filaments   
Chapter 2 Tetrahymena thermophila      Pages 11-16 
2.1 Culture and feeding 
2.2 Nucleus 
2.3 Conjugation 
2.4 Over-expression Vector for Tetrahymena      
2.5 Cytoskeletal Proteins in T. thermophila 
A. Microtubules 
B. Actin 
2.6 Myosin in Tetrahymena 
2.7 What is the Function of Myo1 in Tetrahymena thermophila? 
Chapter 3  Objectives and Experimental Design    Page17 
 viii 
 
Chapter 4 MyTH4 and FERM Have Overlapping Functions in Myo1  Pages 18-40 
4.1 Genomic Analysis of Myo1 
4.2 Bioinformatic Analysis of MyTH4 and FERM  
4.3 Putative Binding Motifs in MyTH4 and FERM  
4.4  MyTH4 Overexpression Constructs  
4.5  FERM Overexpression Constructs  
4.6 MyTH4 Overexpression in Transformed Tetrahymena. 
4.7 Antiactin Antibody Coprecipitates GFP-MyTH4  
4.8 AntiGFP Affinity Pulls Down GFP-MyTH4, Tubulin, and Actin 
4.9 GFP-Myo1 Tail Fusions Interact With Actin and Tubulin  
4.10 GFP-MyTH4 Associates With Parallel Arrays of Crosslinked Exogenous 
Microtubules and Crosslinked Exogenous F-actin 
4.11  Cosedimentation Assays of MyTH4 With f-Actin or Microtubules  
4.12  FERM Overexpression in Tetrahymena thermophila  
4.13 Antiactin Antibody Coprecipitates GFP-FERM 
4.14 Antiactin Immunoprecipitation Pellets Contain GFP-FERM Fusions 
That Interact With f-Actin and Microtubules  
4.15  Cosedimentation Assays of FERM With f-Actin or Microtubules  
Chapter 5 MyTH4 and FERM Have Distinct Functions in Myo1  Pages 41-57 
5.1 GFP-MyTH4 Localizes to Myo1 Targets but Predominately in the 
Nucleus  
5.2 GFP-FERM Fusions Localize to Myo1 Targets but Predominately in the 
Cytosol  
 ix 
5.3 GFP-MyTH4 Affects Division of the Macronucleus 
5.4 GFP-MyTH4 Affects the Organization of the Intramacronuclear 
Microtubule Array and Elongation of the Macronucleus 
5.5 Overexpression of a Truncated MyTH4  
5.6 GFP-FERM Affects the Trafficking of Phagosomes and Membrane  
Chapter 6 Discussion for MyTH4 and FERM     Pages 58-72 
6.1 Overexpression of GFP fusions. 
 6.2 MyTH4 Interacts With Intranuclear Tubulin and Actin  
6.3 MyTH4 Localizes to Myo1 Targets and Affects Myo1 Function 
 6.4 Elongation and Constriction of the Macronucleus 
6.5 Overexpression of GFP-MyTH4 Affects Organization of the MT Array, 
a Possible Driving Force for Elongation of the Macronucleus 
6.6 GFP-MyTH4 Affects Myo1 Function 
6.7  Proposed Model for Interaction Between MyTH4 and Microtubules 
6.8 Analysis of GFP-FERM Overexpression in Tetrahymena thermophila 
6.9 Myo1 FERM Interacts with Actin-filaments and Microtubules. 
 6.10 FERM is Involved in Localization of Myo1. 
 6.11 Phagosome Motility on Cortical Rows of Basal Bodies?  
6.12 MyTH4 and FERM Have Overlapping and Distinct Roles in Myo1  
Chapter 7 Concluding Summary      Pages 73-75 
Chapter 8 Methods        Pages 76-91  
Chapter 9 Closing Remarks      Pages 92-93 
 
Chapter 10 Bibliography        Pages 94-107 
 x 
 List of Figures 
Figure   Description       Page  
1   Myo1 Diagram      18 
2   MyTH4 Alignment      20 
3   FERM Alignment      22 
4   MyTH4 Constructs      24 
5   FERM Constructs      25 
6   MyTH4 Blots       26 
7   MyTH4 Cosedimentation     31 
8   FERM Blots       34 
9   FERM Cosedimentation     37 
10   FERM Cosedimentation II     39 
11   MyTH4 Localization      42 
12   FERM Localization      45 
13   MyTH4 Functions in Amitosis    47 
14   MyTH4 Functions in Macronuclear Elongation  51 
15   MyTH4 Functions in Macronuclear Elongation II  53 
16   FERM Functions in Phagosome Trafficking   57 
17   Model for MyTH4 Function     64 
List of Tables 
Table   Description       Page 
1   Localization of Myo1 MyTH4 and FERM domains  72 
 
 1 
Chapter 1 Myosin Structure and Function 
 
1.1 Discovery of Myosin  
Myosin was first isolated and described by Willi Kuhne in 1864, as a “proteid” 
found in the extracts of frog leg muscles and was later isolated from rabbits (Halliburton, 
1887). The role of myosin in muscle contraction led to several very important 
observations. Myosin was shown to be an ATPase (Engelhardt and Lyubimowa, 1939). 
Straub isolated the activator of myosin and named it actin for its ability to activate the 
ATPase catalytic ability of myosin (Straub, 1942; Straub, 1943). Magnesium ion was also 
shown to be involved in myosin ATPase activity by Banga and et al., (Banga, 1942; 
Banga and Szent-Gyorgi, 1942). The sliding filament model for muscle contraction 
explained the role of myosin and actin in muscle contraction (Huxley, 1954). Ultimately, 
the discovery of a non-conventional or non-filament forming myosin in Acanthamoeba 
castellani (Pollard and Korn, 1973) ushered in the study of non-conventional myosins. 
1.2 General Organization of Myosins  
The super-family of myosin consists of  ~35 classes, with ~2,300 members 
grouped according to homology in their motor domains (reviews, Berg et al., 2001; 
Williams and Gavin, 2005; Richards and Cavalier-Smith, 2005; Foth et al., 2006; 
Ordronitz and Kollmar, 2007). All myosins are actin-dependent molecular motors that 
utilize the power released in the hydrolysis of ATP to translocate along actin “tracks” 
(Lymn and Taylor, 1971) in a process known as acto-myosin mediated translocation. 
Myosins are usually composed of two domains. The N-terminus or motor domain is a 
highly conserved region among myosins.  It has the site for ATP hydrolysis and a site for 
actin binding, (see review, Gavin, 2001). The C-terminus or tail domain varies greatly 
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among myosins. The conventional or filament forming myosins are categorized as class 
II myosins. The unconventional or non-filament forming myosins make up the other ~34 
super-classes (Richards and Cavalier-Smith, 2005). Class II myosins have long segments 
of coiled-coil (CC) regions in their tails. This allows them to form thick filaments as seen 
in muscle-cells. Because conventional myosins dimerize through their CC domain, many 
class II myosins can work together to exert a large amount of force as in muscle flexing. 
Non-filamentous forming myosins (Pollard and Korn, 1973) usually have truncated tails. 
Unconventional myosins have several other types of domains in their tails that allow 
myosins to function in specialized cellular activities, such as intracellular trafficking 
(Durbach et al., 1996, Barsoum and King-Smith, 2007), intranuclear trafficking (Chuang 
et al., 2006), and to function in mammalian motile and sensory cilia (Wolfrum et al., 
1998). 
1.3 What are the Different Myosin Homology Tail Domains? 
It is presumed that the differences in the myosin tail domain allow myosins to be 
utilized in a great diversity of function. Class I myosins localize to the leading edge of the 
lamellipodial projections of migrating Dictyostelium amoeba (Fukui, 1989) and to 
Acanthamoeba lipids (Adams and Pollard, 1989) that are transported in vitro along 
actin tracks (Adams and Pollard, 1986). Acanthamoeba class I myosins (Pollenz, 
1992) contain three distinct myosin tail domains termed tail homology (TH) regions TH-
1, TH-2 and TH-3 (Lee et al., 1999). The TH-1 domain is basic and binds lipids 
(Doberstein and Pollard, 1992); the TH-2 region is Gly/Pro/Ala-rich (GPA) and binds 
actin (Lee et al., 1999; Yu and Bement 2007); and the TH-3 region has a 55-residue src 
homology-3 domain that binds to the PXXP region of the Acan125 protein (Xu et al., 
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1997). MyTH4 (myosin-tail-homology-4) (Chen et al., 1996) domain is often coupled 
with band 4.1-ezrin-radixin-moesin (FERM) as in myosins VII, X, XV (Bohil et al., 
2006), XIV (review, Williams and Gavin, 2005), and in the N-terminus of KCBP 
(kinesin-like-calmodulin-binding protein) (reviews, Berg et al., 2001; Richards and 
Cavalier-Smith, 2005).  
1.4 MyTH4 Domain 
MyTH4 is usually adjacent to a FERM domain, although two of the Tetrahymena 
myosins contain either a MyTH4 or FERM but not both (Williams and Gavin, 2005), and 
in class IV and class XXIII myosins, MyTH4 exists without FERM (Coluccio, 2008).  
MyTH4 in a kinesin exists independent of FERM (Narasimhulu and Reddy, 1998), and 
FERM exists independent of MyTH4 in a kinesin-like protein (Awan et al., 2004) and in 
ERM (ezrin, radixin, moesin) family proteins (Reviewed by Bretscher et al., 2002).  
Distinct functions for the two domains have generally not been established, and 
MyTH4/FERM is often described as a single functional complex with actin and tubulin-
based roles.  Relatively few studies focus on the role of one domain independent of the 
other.  MyTH4 in a plant kinesin directly binds to microtubules (Narasimhulu and Reddy, 
1998), but in Myosin X, both MyTH4 and FERM are required for maximal microtubule 
association (Weber et al., 2004).  
1.5 FERM Domain 
The founding member of the FERM superfamily, protein 4.1-band, was first 
recognized as an isolate that acted in the linking of the erythrocyte membrane proteins 
with spectrin and actin. Protein 4.1-band has been isolated from many other tissues and 
organs such as the bone marrow, cerebellum, lungs, testes and thymus (Conboy et al., 
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1986; review, Diakowski, 2006). Members of the FERM superfamily now include: 
protein 4.1 band, talin, merlin, protein-tyrosine-phosphatase (PTPH), novel band 4.1-like-
4 (NBL4), and ezrin-radixin-moesin (ERM). (review, Diakowski, 2006). The x-ray 
crystallography of highly conserved ERM proteins, human moesin, shows that the FERM 
domain forms a compact clover-leaf shaped structure made of three different lobes (1-3) 
each showing similarity to known structures: ubiquitin, acyl-CoA-binding protein, and 
the pleckstrin-homology (PH)/ phosphotyrosine-binding (PTB)/ enabled-VASP-
homology-1 (EVH1) domain, respectively (Pearson, et al, 2000). Similarly, the x-ray 
crystallography of mouse merlin revealed that the FERM domain also forms a cloverleaf 
structure that consists of the previously described lobes (Shimizu et al., 2002).  
Several proteins contain a FERM (band 4.1-ezrin-radixin-moesin homology) domain 
that interacts with the actin and microtubule cytoskeleton (Bretscher et al. 1997; Chishti 
et al., 1998; Mattagajasingh, 2000; Muranen et al., 2007; Yan, 2001).  ERM family 
proteins consist of an N-terminal FERM domain, an alpha helical domain, and a C-
terminal ERM association domain (C-ERMAD) (Reviewed by Bretscher et al., 2002).  
Each of the three domains contains one or more binding motifs for intramolecular or 
intermolecular associations (Hamada et al., 2000; Li et al., 2006; Pearson et al., 2000).  
Structural studies of the FERM domain reveal three sub-domains (F1, F2, F3 or A, B, C) 
that are potential binding surfaces for proteins, peptides or phospholipids (Pearson et al., 
2000; Kitano et al., 2006).  In vitro, FERM binds to actin (Lee et al., 2004), tubulin 
(Muranen et al., 2007), membrane proteins (Yonemura et al, 1998), and phospholipids 
(Niggli et al., 1995; Hamada et al., 2000).  Studies of the interaction between adhesion 
proteins and ERM proteins reveal that in vivo, ERM proteins exist in either an active or 
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inactive form.  In the inactive or masked state, FERM binds intra-molecularly to the C-
ERMAD, an interaction that partially blocks the FERM surface effectively masking 
binding sites within FERM (Pearson et al., 2000).  Unmasking or activation of ERM 
proteins involves phosphorylation of the tail domain and lipid binding, which release 
FERM from its intra-molecular binding and unmask binding sites (Hamada et al., 2000; 
Pearson et al., 2000).  Crystal structures of radixin show that FERM bound to the 
adhesion molecule ICAM-2 (Inter-Cellular Adhesion Molecule) recognizes the C-
ERMAD sequence RxxTYxVxxA (Hamada et al., 2003).  Crystal structures of moesin 
reveal another binding site within FERM.  Binding of moesin to EBP50 (ezrin binding 
protein) is prevented in dormant moesin in which FERM binds to a conserved 11-aa 
(TKQRIDEFEAL) motif in the C-ERMAD.  In the active state, moesin FERM binds to 
the same 11-aa motif in EBP50 (Finnerty et al., 2004).  Crystal structure of dimerized 
radixin FERM domains reveals that the C-terminal conserved motif (KxxTIxVxxM) in 
one FERM molecule binds sub-domain C within the other FERM molecule (Kitano et al., 
2006).  Studies of liposomal membranes demonstrate that ERM family proteins (such as 
talin, 4.1 and ezrin) destabilize membranes and induce large holes in the membrane 
bilayer (Saitoh et al., 1998; Takeda et al., 2006). Membrane hole formation preferentially 
occurs with neutral and acidic phospholipids, is reversible, and involves both FERM and 
the C-terminus of ERM family proteins  (Saitoh et al., 1998; Takeda et al., 2006). 
One of the 4.1 isoforms termed 4.1R is a mitotic microtubule associated protein and 
has been shown to partially co-localize with tubulin (Huang et al., 2004). The 30-kDa N-
terminus membrane binding domain of 4.1R, termed FERM, is involved in 
intramolecular interactions with other members of FERM (Pérez-Ferreiro, 2006). Using a 
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yeast two-hybrid assay, two isoforms (~135 and ~150 kDa) of 4.1R have been shown to 
interact with actin at tight junctions (Mattagajasingh et al., 2000). Ezrin and its homologs, 
radixin, moesin, and merlin are concentrated in microvilli and can interact with F-actin to 
link microfilaments to membrane (Bretscher et al., 1997). Merlin binds to microtubules 
and actin through its FERM domain (Xu and Gutman, 1998; Taru et al., 2007). 
TalinA is another of the FERM proteins that has the FERM N-terminus extension, it 
has been shown to link the actin cytoskeleton to beta-3-integrin cytoplasmic domains 
(Yan et al., 2001) and to interact with a previously uncharacterized region of Myosin VII 
in Dictyostelium (Tuxworth et al., 2005). The actin-binding sequence in talin FERM has 
been elucidated in humans, mouse, Dictyostelium and other model organisms (Lee et al., 
2004). 
1.6 What is Known About the Function of MyTH4/ FERM Coupling in 
Myosins? 
The precise function of MyTH4/FERM coupling is poorly understood, but it is 
believed to act as a “cross bridge” for microtubule and microfilament interaction either 
through direct contact or the recruitment of protein partners that can interact with both 
cytoskeletal proteins (Reddy and Reddy, 1999). A yeast two-hybrid assay showed that 
Shroom2, an F-actin binding protein, binds to the FERM domain of myosin VIIa 
(Etournay, 2007). 
Human myosin VII contains MyTH4/FERM coupled twice and mutations to this 
myosin causes Usher Syndrome as well as deafness (Wolfrum et al., 1998). Myosin VIIA 
is also localized to mammalian cochlear stereocilia (Hasson et al., 1997) and is necessary 
for Drosophila auditory organ development (Todi et al., 2008). A MyTH7 (myosin-tail-
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homology-7) domain has been identified as a conserved region in the third lobe of the 
cloverleaf structure in both FERM domains of myosin VII (Kiehart et al., 2004) and 
binds actin (Yang et al. 2009). 
Myosin X is required for nuclear anchoring and spindle assembly in Xenopus 
oocytes (Weber et al., 2004). Myosin X binds to microtubules through its MyTH4/FERM 
domain (Weber et al., 2004). The MyTH4/FERM coupled domain in class X myosin also 
participates in the formation of dorsal filopedia in Hela Cells (Bohil et al., 2006). The 
FERM domain of myosin X can reorganize F-actin in COS-1 cells (Yonezawa, 2003). 
The tail region of myosin X post IQ recognizes fascin bundled actin-filaments (Nagy and 
Rock, 2010).  
Mutations to myosin XVa cause deafness in humans and mice, and shakers 
syndrome in mice. Myosin XVa localizes to the tips of cochlear and vestibular hair cell 
stereocilia in mice and is necessary for the proper formation of staircase-like arrangement 
of stereocilia in mature hair bundles (Belyantseva et al., 2003). Myosin XVa is required 
for programmed stereocilia elongation (Belyantseva et al., 2005). Sisyphus, the 
Drosophila myosin XV homolog, contains an additional MyTH4 in conjunction with a 
MyTH4/FERM coupled domain that is required for trafficking of alpha-tubulin and 
tubulin-associated proteins such as Katanin-60, EB1, and Milton (Liu et al., 2008). RNAi 
knockdown of sisyphus disrupts the organization of both the actin and microtubule 
cytoskeletal (Liu et al., 2008). Although Myosin V does not contain a MyTH4/FERM 
coupling, immunofluorescence staining with antibodies against myosin Va revealed 
localization to microtubule rich regions such as the microtubule organizing center and to 
the mitotic asters, spindle, and the mid-body of dividing cells in a variety of cell types, 
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including primary and immortal mouse melanocytes and fibroblasts, Hela cells, and Cos 
cells (Wu et al., 1998). MAX-1 is a neuronal guidance protein, conserved among 
drosophila and humans. MAX-1 has a MyTH4/FERM domain and the FERM domain is 
required for the proper localization of MAX-1 (Huang et al., 2002).  
1.7   MyTH4 and FERM Domains in Kinesins 
 The MyTH4 domain in the C-terminus of an Arabidopsis KCBP binds to 
microtubules (Reddy and Reddy, 1999; Narasimhulu, 1998). A kinesin II kinesin-like-
protein (Klps), kin5, in T. thermophila has a FERM domain in its tail and localizes to 
components of the intraflagellar transport system (Awan et al., 2004). The authors 
speculate that the Kin5 FERM interacts with membrane proteins (Awan et al., 2004). 
  1.8  Myosin in the Nucleus? 
Initial fluorescence recovery after photobleach (FRAP) experiments suggested 
that the role for actin and myosin in nuclear transport was in controlling the pore size of 
the nuclear pore complex (Schindler and Jiang, 1986). Class I myosins target the nucleus 
by an N-terminus extension (Pestic-Dragovich et al., 2000), localize to active nucleoli in 
human cells, interact with RNA polymerase I complex (Percipalle et al., 2006), and play 
a role in transcription activation with actin (Ye et al., 2010). Nuclear Myosin I localizes 
to dense fibrillar component sites of active Pol I transcription and rDNA processing in 
contrast to nuclear actin which predominately reside in Fibrillar Centers, sites of of Pol I 
and transcription storage. (Philimonenko et al., 2010, and reviews within). One of the 
three class V myosin paralogs, Myo5a, localizes to active DNA transcriptional regions in 
the nucleus (Pranchevicius et al., 2008), termed speckles, and has been implicated in 
trafficking mRNA from the nucleus to cytosolic destinations  (Salerno et al., 2008). The 
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globular tail of myosin Vb fused to a GFP-tag localized to active transcriptional regions 
of the nucleus, termed nucleoli, in Hela cells (Lindsay and McCaffrey, 2009). 
Accordingly, myosin Vb has been shown to interact with beta-actin and RNA polymerase 
I by coimmunoprecipitation studies (Lindsay and McCaffrey, 2009). A class V myosin in 
Saccharomyces cervisiae, Myo4p is involved in transporting mRNA of ASH1 in cell 
determination (Chartland and et al., 2002). The Myo16a tail and may target the nucleolus 
by ankryin repeat domains and colocalizes with actin, and cyclin A in the nucleus 
(Cameron et al., 2007). 
1.9 Myosin Function in Regulating Actin Dynamics 
Actin dynamics can be used by cells for intracellular trafficking (Basciano and 
King-Smith, 2002; McNeil et al., 2004). Filopodia and lamellipodia are cytoplasmic 
protrusions that contain actin bundles. Myosin-X (Myo10) is ubiquitously expressed in 
human cells, and localizes at sites of dynamic actin and actin-rich ruffles at the tips of 
lamellipodia in an actin-independent manner (Berg et al., 2000). Over-expression of 
GFP-Myo10 in mouse intraembryonic endothelial cells (MECs) increases the number of 
filopodial extensions (Pi et al., 2007). The tail region of myosin-X, that is C-terminal to 
the IQ domain, recognizes fascin bundled actin-filaments (Nagy and Rock, 2010). Myo10 
colocalizes with Mena/VASP and interacts with the Mena/VASP complex to promote 
actin growth at filopodia tips in Hela cells (Tokou and Ikebe, 2004). Myo10 initiates 
filopodia formation as a dimerized motor truncated for the MyTH4/FERM region in 
COS7 and NIH3T3 cells (Tokou et al, 2007). Interestingly, the MyTH4/FERM domain of 
Myo10 binds to NPXY in integrins (Zhang et al., 2004).  
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1.10 Interaction among Microtubules and Actin-filaments   
Reviews for complementary (Langford, 1995) and synergistic (Gavin, 1997; 
Gavin, 1999) roles for microtubule and filamentous actin have elucidated but have not 
fully explained the mechanism of the interactions between the microtubule and f-actin 
cytoskeletal polymers.  Viscometry experiments in 1978 first revealed actin filament-
microtubule interaction mediated by microtubule-associated-proteins (MAPs) (Griffith 
and Pollard, 1978). Bovine brain derived microtubule-associated-proteins-2 (MAP-2) co-
sediments Rabbit psoas (psoas is muscle from the abdomen) actin in a ratio of ~1 
molecule of MAP-2 to 28 molecules of actin (Sattilaro et al., 1981). Affinity 
chromatography and electron microscopy studies have shown that the tubulin binding 
sequences of tau (Lewis et al., 1988), which is similar to the MAP-2 tubulin binding 
sequence (Lewis et al., 1988; Doll et al., 1993), binds actin (Correas, et al., 1990). 
Microscopy and co-sedimentation assays have shown that the previously described actin-
binding domains in FERM bind tubulin in ezrin and its homolog in merlin (Muranen et 
al., 2007). The actin based molecular motor, myosin-Va, has been shown by microscopy 
and co-sedimentation assays to mechanochemically couple MTs to actin filaments (Cao 
et al., 2004). 
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Chapter 2 Tetrahymena thermophila 
 
2.1 Culture and Feeding 
 Tetrahymena thermophila, formerly known as T. pyriformis variety 1 or syngen 1 
(Nanney and McCoy, 1976), is a free living, heterotrophic, ciliated protist that has been 
adopted as a model organism for the study of many cellular processes. The oral apparatus 
(OA) of Tetrahymena is a large cortical feeding structure, consisting of ciliated basal 
bodies (Gavin, 1980). Tubulin (Williams, 1986; Williams and Honts, 1987), actin (Hirino 
et al., 1987; Hoey and Gavin, 1992; Hosein et al., 2005), myosin (Garcés et al., 1995), 
and centrin (Guerra et al., 2003) localize to the OA of T. thermophila. Phagosomes form 
in the OA, at the base of the buccal cavity (Kitajima and Thompson, 1977). Cytochalasin 
B, is an inhibitor of actin polymerization and has been shown to disrupt phagocytosis 
process in Tetrahymena, including the area around the OA (Hoffmann et al., 1974). 
Tetrahymena can grow in the absence of phagocytosis (Rasmussen and Orias, 1975) by 
utilizing clathrin-dependent endocytosis (Elde et al., 2005). Endocytosis occurs at 
membrane sites adjacent to cilia, including cilia that compose the oral apparatus (Nillson 
and Van Deurs, 1983). Phagosomes and endosomes fuse with lysosomes (Kitajima and 
Thompson, 1977). Of the 73 putative Tetrahymena phagosome proteins identified, 28 
have been implicated in the phagocytosis process in other organisms (Jacobs et al., 2006). 
After food is processed in phagosomes, unwanted material is released back to the 
environment and the surrounding membrane is recycled at the cytoproct, a membrane 
structure located in the posterior of the cell (Kitajima and Thompson, 1977; Allen and 
Wolf, 1979). Actin localizes to the cytoproct and treatment of Tetrahymena with 
Latrunculin B disturbs the shape of the cytoproct, however treatment with Nacodozole, a 
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microtubule depolymerizing agent, inhibits the egestion of food vacuoles through the 
cytoproct (Sugita et al., 2009) 
 2.2  Nucleus 
 Tetrahymena thermophila exhibits nuclear dimorphism; it has a somatic 
macronucleus (MAC) and a germline micronucleus (MIC). The MAC contains ~45 
copies of each chromosome and is active during vegetative growth. The MIC has five 
chromosomes and is only active during sexual reproduction. During vegetative growth 
the MAC elongates and constricts, and its contents are divided into two approximately 
equal subnuclei (Orias, 1991), a process known as amitosis. Amitosis involves the 
macronuclear microtubules (Williams and Williams, 1976), without much chromosomal 
condensation in the MAC (Flickinger, 1965). During cytokinesis, cytoplasmic and 
macronuclear microtubules respectively organize in the cytoplasm and the MAC to aid in 
macronuclear division (Numata et al., 1999). The Tetrahymena macronucleus genome 
was sequenced (Eisen et al., 2006) and has been open to the public as of 2/2/04 at the 
Tetrahymena Genome Database (ciliate.org). The micronucleus divides mitotically, and 
two G-DNA-binding proteins, TGP1 and TGP2, aid in micronuclear division (Lu and 
Henderson, 2000). 
 2.3 Conjugation 
Tetrahymena thermophila is sexually active, having 7 different mating types 
controlled by the mat locus, which is adjacent to the ribosomal RNA gene (Bleyman, 
1992).  A zygotic nucleus forms through fusion of a pronucleus from each conjugant. The 
zygotic nucleus develops into two new genetically matched macronuclei and micronuclei, 
and the pre-existing macronucleus is eliminated. The first cell division of exconjugants 
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produces cells with a genetically matched macronucleus and micronucleus.  
 2.4 Overexpression Vector for Tetrahymena      
Ribosomal DNA (rDNA) based vectors (Tondravi and Yao, 1986; Yao, 1986) are 
used to transform T. Tetrahymena (Gaertig et al., 1994) by inducing the amplification of 
engineered rDNA constructs. pIGF-1, created by M.C. Yao, is commonly used for the 
over-expression of genes in Tetrahymena. The pIGF-1 cloning site consists of an MTT1 
promoter (Shang et al., 2002) that is inducible by ionic cadmium, a GFP gene, and a 
transcriptional stop sequence. The vector also contains Tetrahymena and bacterial origins 
of replication and genes for neomycin and ampicillin resistance. Genes of interest are 
cloned 3’ to the GFP site in pIGF-1 and therefore are expressed with an N-terminus GFP 
tag. Biolistic bombardment (Cassidy-Hanley et al., 1997; Bruns and Cassidy-Hanley, 
2000) is used to insert the vector into Tetrahymena mating cells, when they are forming 
new macronuclei during conjugation. Transformants are selected by antibiotic resistance. 
2.5 Cytoskeletal Proteins in T. thermophila 
A. Microtubules 
Microtubules localize to basal bodies, ciliary axonemes, and other regions of the 
cortex. The Tetrahymena thermophila genome contains genes for one alpha-tubulin 
(ATU1), one gamma-tubulin (GTU1), and two beta-tubulin genes (BTU1 & BTU2) 
(Libisova and Draber 2006). Tetrahymena expresses three alpha-tubulin and two beta-
tubulin isotypes, three of the alpha isotypes and one of the beta isotype is exclusively 
found in ciliary microtubules (Suprenant et al., 1985). Gamma-tubulin localizes in 
vegetative cells to basal bodies (BBs), macronuclear envelopes, micronuclear envelopes, 
and contractile vacuole pores (Shang et al., 2002).  
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B. Actin 
Act1 is the least divergent of the four Tetrahymena actin homologs (Williams et al., 
2006). ACT1 consists of 1128 nucleotides and lacks any introns (Cupples and Pearlman, 
1986). The actin protein consists of 375 amino acids, 74% identical to yeast actin and is 
predicted to have a mass of 42 kDa (Cupples and Pearlman, 1986).  Tetrahymena actin 
shares ubiquitous features with its homologs that include polymerization into filaments in 
the presence of potassium and magnesium ions, and the decoration of heavy mero-
myosin (Hirono et al., 1989). Cytochalasin B (Spuddich and Lin, 1972), and Latrunculin 
A (Coué et al., 1987) are commonly used drugs that inhibit actin polymerization, 
conversely, phalloidin promotes actin polymerization (Lengsfeld et al., 1974). 
Phalloidin, however, does not bind to Tetrahymena actin (Hirono et al., 1989). 
Immunobodies raised against a synthetic actin N-terminus peptide localized to the 
division furrow of dividing cells, as well as the oral apparatus, phagosomes, cytoproct, 
ciliary meridians and intranuclear microfilament bundles induced by various stresses 
(Hirono et al, 1987). Immunogold labeled anti-actin localized to actin epitopes in four 
distinct regions of a filamentous complex that surrounds each basal body in the oral 
apparatus (Hoey and Gavin, 1992). GFP-tagged actin localized to basal bodies, 
phagosomes, and cytokinesis-related contractile ring in dividing cells (Hosein et al., 
2003). Phenotype of the ACT1 knockout include: paralysis in motility, arrested 
cytokinesis, deficiencies in phagosome formation and minor aberrations in ciliary 
axonemes (Williams et al., 2006). The mRNA levels of ACT1 is very similar to that of 
ATU1 (alpha-tubulin) and BTU2 (beta-tubulin). 
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2.6 Myosin in Tetrahymena 
Myo1 is the founding member of the 13 Tetrahymena thermophila myosins 
(Garcés and Gavin, 1998). Myo1 was initially assigned to myosin class XX but more 
recently re-assigned to a subclass within class XIV (reviews, Berg et al., 2001; Williams 
and Gavin, 2005; Foth, 2006). The tail of this myosin contains a MyTH4/FERM coupled 
domain. Myo1 has a mass of 210,889 Daltons and contains 1809 amino acids that include 
an 89 amino acid N-terminus extension to the 756 amino acid motor, a MyTH4 (myosin-
tail-homology 4) domain that extends from amino acid 1234 through and including 1376, 
and a FERM domain that extends from amino acid 1381 through and including 1799. The 
Myo1 motor contains a putative internal calmodulin-binding site, termed IQ (review, 
Cheney, 1992; Rhoads and Friedberg, 1997; Gillespie and Cyr, 2002), which begins with 
amino acid 758 and ends in amino acid 769.   
2.7 What is the Function of Myo1 in Tetrahymena thermophila? 
Despite the redundancy of 13 myosins in T. thermophila a somatic knockout (KO) 
of MYO1 in Tetrahymena thermophila displays a phenotype (Williams et al., 2000); and 
in the last 10 years, this KO has enhanced our knowledge in understanding the inner-
workings of cellular trafficking in Tetrahymena (Hosein et al., 2005; Hosein and Gavin, 
2007).  Some of the morphological abnormalities in Myo1 mutants include: smaller 
cytoplasmic to nuclear ratio, defect in macronuclear elongation which probably explains 
the longer doubling time at 20ºC, and reduced rate of vacuole formation at 20ºC 
(Williams et al., 2000). In the KO phagosome motility was random in contrast to wild 
type Tetrahymena in which phagosomes moved in a directed manner toward the posterior 
of the cell (Hosein et al., 2005). A peptide polyclonal antibody targeting the motor 
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domain of Myo1 localized to phagosomes and the nucleus (Hosein and Gavin, 2007). 
Some phagosomes trafficked to the macronucleus in a Myo1 dependent manner (Hosein 
and Gavin, 2007). The authors speculate that trafficking of phagosomes to the nucleus 
could transport actin and myosin to the nucleus where they function in amitosis (Hosein 
and Gavin, 2007).  
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Chapter 3  Objectives and Experimental Design 
 
Objective 
An objective of this research project is to determine how Myo1 localizes to 
microtubule and actin targets within the cell. An additional objective is to determine 
whether MyTH4 or FERM region is sufficient for localization to Myo1 targets. We also 
wish to determine whether MyTH4 and FERM have overlapping or distinct roles in the 
function of Myo1.                                                                                                                                                                                                                                                                            
Hypothesis 
 Myo1 is hypothesized to interact with microtubule and actin filament sites 
through its MyTH4/FERM coupling. MyTH4 and FERM are hypothesized to bind to MT 
and AF, respectively. MT-linked MyTH4 and AF-linked FERM are hypothesized to 
synergistically direct Myo1 to its targets.  
Experimental Approach & Design 
The general experimental approach was to create truncations of Myo1 that contain 
various regions of the MyTH4/FERM coupling.  The truncated myosins were expressed 
in Tetrahymena.  Expressed truncations were localized by confocal microscopy and 
analyzed for binding partners by low speed cosedimentation assays, 
coimmunoprecipation, and coimmunoflorescence. 
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Chapter 4 MyTH4 and FERM Have Overlapping Functions in Myo1 
 
4.1 Genomic Analysis of Myo1 
MYO1 consists of 6,337 base pairs (bp) accession number TTHERM_00112430, 
is located on positions 101,149 through and including 107,485. MYO1 has 8 introns that 
are spliced out to create a 5,430 bp mRNA transcript that includes a TGA stop triplet.  
Myo1 has a mass of 210,889 Daltons with a theoretical pI of 8.76. Myo1 contains 
1,809 amino acids (Fig 1)  that include an 89 amino acid N-terminus extension to the 756 
amino acid motor, a MyTH4 (myosin-tail-homology-4) domain that extends from amino 
acid 1,234 through and including 1,376, and a FERM domain that extends from amino 
acid 1,381 through and including 1,799. The Myo1 motor contains a putative internal 
calmodulin-binding site, termed IQ (review, Cheney, 1992; Rhoads and Friedberg, 1997; 
Gillespie and Cyr, 2002), which begins with amino acid 758 and ends in amino acid 769.  
Fig. 1 
 
Fig. 1.  Myo1, a class XIV myosin.  (A)  Diagram of Myo1.  The oval (aa 1-89) 
represents the N-terminal extension. The location of MyTH4 was determined by prosite 
(Hulo and et al.,  2007). The location of FERM was determined by alignment of the 
Myo1 tail domain with Mus radixin.   
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4.2 Bioinformatic Analysis of MyTH4 and FERM  
To search for possible binding motifs that could form the basis for MyTH4 
interactions, MyTH4 was aligned with sequences that involve actin binding, tubulin 
binding, FERM-FERM interactions and nuclear localization.  Lee et al. (2004) identified 
a cluster of FERM domain amino acids that were proposed to mediate an electrostatic 
interaction between actin and talin.  In the present study we sought to determine whether 
the same cluster of amino acids exists in MyTH4 and, therefore, represent a putative 
binding site for actin.  The MyTH4 sequence was aligned with the actin-binding site 
(ABS1) in the N-terminal FERM domain of Dictyostelium talinB (Lee et al., 2004) and 
with one of the four tandem repeats in the tubulin-binding domain of Rattus MAP-2 (Doll 
et al., 1993) (Fig. 2).  The talin (ABS) and MAP-2 (TBS) sequences loosely matched two 
non-overlapping sequences in MyTH4 (Figs. 2A-2B).  Alignment of the MyTH4 
sequence with (PPKKKRKVED), the  nuclear localization sequence (NLS) in Simian 
virus 40 large T antigen, revealed an NLS-like sequence in MyTH4 (Fig. 2C).  Myo1 
FERM (Gotesman et al., 2010) contains a sequence that loosely matched a conserved 
radixin FERM sequence (Kitano et al., 2006) reportedly involved in dimerization of 
radixin FERM.  The alignment in Fig. 2D revealed a similar sequence in MyTH4. 
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Fig. 2 
 
Fig. 2.  MyTH4 Clustal W alignments.  Portions of the MyTH4 sequence are not 
shown. (A)  Clustal W alignment of Myo1 MyTH4 and the actin-binding sequence in the 
N-terminal FERM domain of Dictyostelium talinB.  Putative actin-binding sequence in 
Myo1 MyTH4 (aa 1249-1348): Identities = 15/51(29%), Positives = 36/51(70%).  (B)  
Clustal W alignment of Myo1 MyTH4 and the tubulin-binding sequence in Rattus MAP-
2.  Putative tubulin-binding sequence in Myo1 MyTH4 (aa 1343-1373): Identities = 
4/31(13%), Positives = 17/31(55%).  (C) Clustal W alignment of Myo1 MyTH4 with the 
nuclear localization sequence (PPKKKRKVED) for Simian virus 40 large T antigen.  
Putative NLS in Myo1 MyTH4 (aa 1337-1360): Identities = 4/10(40%), Positives = 
8/10(80%). (D)  Clustal W alignment of Myo1 MyTH4 and the conserved FERM 
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putative imerization motif (KxxTIxVxxM) in Mus radixin.  X= any amino acid.  Putative 
dimerization sequence in Myo1 MyTH4 (aa 1319-1328): Identities = 2/5(40%), Positives 
= 4/5(80%).  
To search for putative binding motifs involving FERM, Myo1 FERM was aligned 
with the actin-binding sequence (ABS1) in the N-terminal FERM domain of 
Dictyostelium talinB (Lee et al., 2004) and with one of the four tandem repeats in the 
tubulin-binding domain of Rattus MAP-2 (Doll et al., 1993).  The talin sequence loosely 
matched two non-overlapping, putative actin-binding sequences in the N-terminal and C-
terminal regions of Myo1 FERM (Fig. 3A).  The MAP-2 sequence loosely matched two 
non-overlapping, putative tubulin-binding sequences in the N-terminal and C-terminal 
regions of Myo1 FERM (Fig. 3B).  The bold face type in Fig. 3A-B indicates amino acids 
that appear in both actin and tubulin-binding sequences.  Alignment of Myo1 FERM with 
the sequence KxxTIxVxxM, a conserved motif involved in dimerization of FERM in Mus 
radixin (Kitano et al., 2006), revealed a closely matched sequence in the N-terminal 
region of the FERM domain and another matched sequence in the FERM C-terminal 
region.  Here, the KxxTIxVxxM motif is referred to as the FERM dimerization sequence 
(FDS) (Fig. 3C).  Alignment of Myo1 with the C-ERMAD sequence (TKQRIDEFEAL) 
(Finnerty et al., 2004) revealed a similar sequence in residues 340-350 in the Myo1 motor 
domain (Fig. 3D).  Alignment of Myo1 with the ERM alpha helical domain sequence 
(TTPxxxxxxE) (Li et al., 2006) revealed a sequence match in Myo1 residues 1046-1055 
C-terminus of the motor domain (not shown).  An additional search for binding motifs 
involved alignment of Myo1 FERM with the nuclear localization sequence 
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(PPKKKRKVED) for Simian virus 40 large T antigen.  Alignment revealed NLS-like 
sequences in both the N-terminus and C-terminus regions of FERM (Fig. 3E). 
Fig. 3. 
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Fig. 3. FERM Clustal W alignments.  Portions of the FERM sequence are not 
shown. (A)  Clustal W alignment of Myo1 FERM and the actin-binding sequence in the 
N-terminal FERM domain of Dictyostelium talinB.  Putative actin-binding sequence in 
Myo1 FERM N-terminal region (aa 1420-1526): Identities = 15/51(29%), Positives = 
34/51(67%).  Putative actin-binding sequence in Myo1 FERM C-terminal region (aa 
1692-1802): Identities = 11/51(22%), Positives = 29/51(57%).  (B)  Clustal W alignment 
of Myo1 FERM and the tubulin-binding sequence in Rattus MAP-2.  Putative tubulin-
binding sequence in Myo1 FERM N-terminal region (aa 1492-1565): Identities = 
5/31(16%), Positives = 20/31(65%).  Putative tubulin-binding sequence in Myo1 FERM 
C-terminal region (aa 1687-1718): Identities = 10/31(32%), Positives = 19/31(61%).  (C)  
Clustal W alignment of Myo1 FERM and the conserved FERM dimerization motif 
(KxxTIxVxxM) in Mus radixin.  X= any amino acid.  Putative dimerization sequence in 
Myo1 FERM N-terminal region (aa 1379-1388): Identities = 3/5(60%), Positives = 
4/5(80%).  Putative dimerization sequence in Myo1 FERM C-terminal region (aa 1689-
1698): Identities = 2/5(40%), Positives = 4/5(80%).   (D)  Clustal W alignment of Myo1 
motor (aa 340-350) with the conserved C-ERMAD sequence (TKQRIDEFEAL). 
Identities = 3/11(27%), Positives = 8/11(73%).  (E)  Clustal W alignment of Myo1 
FERM with the nuclear localization sequence (PPKKKRKVED) for Simian virus 40 
large T antigen. Putative NLS in Myo1 FERM N-terminal region (aa 1431-1450): 
Identities = 7/10(70%), Positives = 7/10(70%).  Putative NLS in Myo1 FERM C-terminal 
region (aa 1743-1752): Identities = 2/10(20%), Positives = 8/10(80%). 
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4.3 Putative Binding Motifs in MyTH4 and FERM  
Overexpression of GFP-MyTH4 and GFP-FERM in Tetrahymena thermophila 
was used to investigate the role of putative actin and tubulin binding motifs in the 
function of MyTH4 and FERM (Figs 4 and 5). GFP-MyTH4 and a truncated version of 
the MyTH4 were separately expressed in Tetrahymena (Fig 4). GFP-MyTH4 contained 
the entire GFP-MyTH4 domain (Fig 4B). GFP-MyTH4T contains the entire MyTH4 
sequence N-terminal to the putative TBS (Fig 4C).  
4.4  MyTH4 Overexpression Constructs  
Fig. 4.  
 
Fig 4. Myo1, a class XIV myosin. (A)  Diagram of Myo1.  The oval (aa 1-89) 
represents the N-terminal extension. Diagrams of constructs prepared from truncated 
Myo1-tail domains. (B) GFP-MyTH4. (C) Truncated GFP-MyTH4.  Actin Binding 
Sequence (ABS) and Tubulin Binding Sequence (TBS) are indicated within the ovals in 
the diagram. 
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4.5  FERM Overexpression Constructs  
GFP-FERM and two truncated FERM domains derived from GFP-FERM were 
separately expressed in Tetrahymena to test putative binding sequences. GFP-FERM 
contained the entire Myo1 FERM domain (Fig. 5B).  Truncated Myo1 FERM domains 
contained either the N-terminal or the C-terminal region of FERM and one putative 
sequence for actin binding, one for tubulin binding, a putative dimerization motif, and a 
NLS-like sequence. 
Fig. 5.  
 
Fig 5. Myo1, a class XIV myosin.  (A)  Diagram of Myo1.  The oval (aa 1-89) 
represents the N-terminal extension. The location of FERM was determined by alignment 
of the Myo1 tail domain with Mus radixin. (B) Diagrams of constructs prepared from 
truncated Myo1-tail domains.  Actin Binding Sequence (ABS) and Tubulin Binding 
Sequence (TBS) are indicated within the ovals in the diagram. 
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4.6 MyTH4 Overexpression in Transformed Tetrahymena 
Expression of GFP-MyTH4 was initiated by addition of cadmium chloride to a 
population of transformed cells previously grown for 8-12 hours.  Over a 12-hr period 
following initiation of over expression, cell density gradually declined, in sharp contrast 
to an untreated control population, which remained in exponential phase of growth.  To 
confirm expression of GFP-MyTH4, total cell lysate was prepared from cells 
approximately 8 hours after induction of overexpression.  The lysate was analyzed on an 
immunoblot probed with GFP antibody, which detected the GFP fusion polypeptide at 
the expected relative molecular mass of 47 kDa (Fig. 6A). 
Fig. 6.  
 
Fig 6. Gel and immunoblot analysis of GFP-MyTH4 overexpressing cells. (A) 
Immunoblot analysis of cells expressing GFP-MyTH4. The blots were probed with 
mouse antiGFP.  Lane 1: GFP-MyTH4. The fusion protein is 47 kDa.  Lane 2: Wild-type 
control.  (B) Gel and immunoblot analysis of antiactin immunoprecipitation pellets (IP) 
from cells overexpressing GFP-MyTH4.  Gel loadings were equal for all lanes.  Lane 1: 
Gel of antiactin IP from GFP-MyTH4.  Lane 2: Blot of antiactin IP from GFP-MyTH4.  
The blot was probed with anti-GFP. The fusion protein is 47 kDa.  Lane 3: Blot of 
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antiactin IP from GFP-MyTH4.  The blot was probed with mouse antitubulin.  Tubulin is 
at 55kDa. Lane 4: Gel of antiactin IP from a strain expressing GFP alone.  Lane 5.  Blot 
of antiactin IP from GFP alone.  The blot was probed with mouse antiGFP. (C) Gel and 
immunoblot analysis of antiactin immunoprecipitation pellet (IP) from cells 
overexpressing GFP-MyTH4. Lane 1: Gel of antiactin IP from GFP-MyTH4. Lane 2: 
Blot of antiactin IP from GFP-MyTH4.  The blot was probed with rabbit antiactin.  Actin 
is at 42 kDa.  The IgG heavy chain is approximately 50 kDa. Lane 3: Blot of antiactin IP 
from GFP-MyTH4.  The blot was probed with rabbit antiMyo1.  Myo1 is at 180 kDa. 
The IgG heavy chain is approximately 50 kDa.  (D) Gel and immunoblot analysis of 
antiGFP pulldown fraction from cells overexpressing GFP-MyTH4.  Gel loadings were 
equal for all lanes.  Lane 1: Gel of affinity purified GFP-MyTH4 fraction.  Lane 2: Blot 
of antiGFP pulldown fraction.  The blot was probed with anti-GFP. The fusion protein is 
47 kDa.  Lane 3: Blot of antiGFP pulldown fraction.  The blot was probed with mouse 
antitubulin.  Tubulin is at 55 kDa.  Lane 4: Blot of antiGFP pulldown fraction.   The blot 
was probed with rabbit antiactin.  Actin is at 42 kDa.  
 
 28 
4.7 Antiactin Antibody Coprecipitates GFP-MyTH4  
Clustal alignments indicated a putative tubulin-binding site and a putative actin-
binding site within MyTH4.  Therefore, to obtain additional evidence that MyTH4 
interacts with tubulin and to investigate MyTH4 interaction with actin, non-denatured 
lysate from a strain expressing GFP-MyTH4 was processed for immunoprecipitation (IP) 
with antiactin, and precipitated proteins were eluted from ProteinA-agarose beads.  Actin 
antibody coprecipitated GFP-MyTH4, tubulin, actin, and Myo1 (Figs. 6B-6C).  The 
expression level of Myo1 in overexpressing cells appeared comparable to the expression 
level in wild type.  In a control experiment, actin antibody precipitated several proteins 
from lysate of cells expressing GFP alone, and the control IP gel is quite similar to the 
GFP-MyTH4 antiactin IP gel (Fig. 6B).  However, GFP was not detected on an 
immunoblot of the control IP (Fig. 6B).   
4.8 AntiGFP Affinity Pulls Down GFP-MyTH4, Tubulin, and Actin 
For affinity purification of GFP-MyTH4, non-denaturing lysate from the GFP-
MyTH4 strain was incubated with antiGFP-linked agarose.  The eluted fraction contained 
several polypeptides including GFP-MyTH4, actin, and tubulin (Fig. 6D).  Myo1 was not 
detected in the eluted fraction. 
4.9 GFP-Myo1 Tail Fusions Interact With Actin and Tubulin 
 To demonstrate that GFP-MyTH4 and GFP-FERM fusions interact with actin and 
tubulin in vivo, non-denatured extracts from cells over-expressing GFP-fusions were 
used in low speed co-sedimentation assays with either exogenous phalloidin (Alexa-Fluor 
568)-stabilized actin filaments or exogenous rhodamine-labeled microtubules.  Phalloidin 
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does not bind to Tetrahymena actin filaments (Hirono et al., 1989), and therefore the 
assay did not detect endogenous F-actin.  
4.10 GFP-MyTH4 Associates With Parallel Arrays of Crosslinked Exogenous 
Microtubules and Crosslinked Exogenous F-actin 
Antiactin IP, antiGFP pulldown fraction, and whole cell extract from the GFP-
MyTH4 strain were separately used in low speed cosedimentation assays with either 
exogenous rhodamine-labeled microtubules or exogenous phalloidin (Alexa-Fluor 568)-
stabilized F-actin (Fig. 7).  Phalloidin does not bind to Tetrahymena F-actin (Hirono et 
al., 1989), and therefore the assay did not detect endogenous F-actin.  To eliminate 
binding of actin to myosin motor domains, actin cosedimentation assays were performed 
in the presence of added 10 mM Mg-ATP.   
4.11  Cosedimentation Assays of MyTH4 With f-Actin or Microtubules  
Examination of the pellet from a cosedimentation assay with microtubules and 
antiactin IP revealed significant colocalization of green (GFP-MyTH4) and red 
(exogenous microtubules) fluorescence (Figs. 7B-7D).  Examination of the pellet from a 
cosedimentation assay with labeled F-actin and antiactin IP revealed significant 
colocalization of green (GFP-MyTH4) and red (F-actin) fluorescence (Figs. 7F-7H).  
GFP alone did not cosediment with either F-actin or microtubules.  Next, we asked 
whether exogenous F-actin affects microtubule aggregation.  A cosedimentation assay 
was performed with a mixture of unlabeled F-actin, rhodamine-labeled microtubules, and 
antiactin IP.  Microtubules appeared to be more extensively crosslinked in the presence of 
F-actin (Figs. 7J-7L, Inset).  Whole cell extract from the GFP-MyTH4 strain was used in 
a cosedimentation assay with either exogenous microtubules (Fig. 7N-7P) or exogenous 
 30 
F-actin (Figs. 7R-7T).  Significant colocalization of the two signals was observed in the 
pellet from each assay.  To rule out non-specific aggregation by GFP, a control 
experiment used F-actin in the presence of 10 mM Mg-ATP and whole cell extract from a 
strain that expressed GFP alone.  Examination of the pellet from the control 
cosedimentation assay did not detect colocalization of red and green fluorescence as 
shown in merged red and green channel images (Fig. 7X).  The antiGFP pulldown 
fraction was used in cosedimentation assays with either exogenous microtubules or 
exogenous F-actin.  Figs. 7AA-HH show that the affinity purified GFP-MyTH4 
cosedimented with exogenous F-actin and exogenous microtubules, consistent with 
cosedimentation assays involving antiactin IP.   The images of crosslinked F-actin and 
crosslinked microtubules appear highly similar in assays involving either antiactin IP or 
the antiGFP pulldown fraction. 
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Fig. 7.  
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Fig 7. Cosedimentation analysis of GFP-MyTH4 overexpresing cells.  Scale bar = 
5 µm. (A-D) Cosedimentation of microtubules (red) and antiactin IP from GFP-MyTH4 
lysate.  (A) Taxol-stabilized microtubules prior to cosedimentation.  (B-D) Pellet from 
cosedimentation of microtubules and antiactin IP. (B) Microtubule signal.  (C) GFP 
signal.  (D) Image from merged red-green channels.  (E-H) Cosedimentation of 
phalloidin-labeled, muscle F-actin (red) and antiactin IP from GFP-MyTH4 lysate.  (E) 
F-actin prior to cosedimentation.  (F-H) Pellet from cosedimentation of F-actin and 
antiactin IP.  (F) F-actin signal.  (G) GFP signal.  (H) Image from merged red-green 
channels.  (I-L) Cosedimentation of microtubules (red), unlabeled muscle F-actin, and 
antiactin IP from GFP-MyTH4 lysate.  (I) Taxol-stabilized microtubules prior to 
cosedimentation.  (J-L) Pellet from cosedimentation of microtubules, unlabeled F-actin, 
and antiactin IP. (J) Microtubule signal.  (K) GFP signal.  (L) Image from merged red-
green channels.  The inset shows a higher magnification of a portion of the microtubule 
cross-linked array.  The bar in (L) represents 18.5 µm for the inset. (M-P) 
Cosedimentation of microtubules (red) and whole cell extract from GFP-MyTH4 strain.  
(M) Taxol-stabilized microtubules prior to cosedimentation.  (N-P) Pellet from 
cosedimentation of Taxol-stabilized microtubules and extract from cells expressing GFP-
MyTH4. (N) Microtubule signal.  (O) GFP signal. (P) Image from merged red-green 
channels. (Q-T) Cosedimentation of phalloidin-labeled, muscle F-actin (red) and whole 
cell extract from GFP-MyTH4 strain. (Q) F-actin prior to cosedimentation.  (R-T) Pellet 
from cosedimentation of F-actin (red) and extract from cells expressing GFP-MyTH4. 
(R) F-actin signal.  (S) GFP signal.  (T) Image from merged red-green channels. (U-V) 
Cosedimentation of F-actin and extract from cells expressing GFP alone. (U) Phalloidin-
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labeled muscle F-actin prior to cosedimentation.  (V-X) Pellet from cosedimentation of 
F-actin and extract from cells expressing GFP alone.  (V) F-actin signal.  (W) GFP 
signal.  (X) Image from merged red-green channels. (AA-DD) Cosedimentation of 
phalloidin-labeled, muscle F-actin (red) and antiGFP pulldown fraction.  (AA) F-actin 
prior to cosedimentation.  (BB-DD) Pellet from cosedimentation of F-actin and antiGFP 
pulldown fraction.  (BB) F-actin signal.  (CC) GFP signal.  (DD) Image from merged 
red-green channels.  (EE-HH) Cosedimentation of microtubules (red) and antiGFP 
pulldown fraction. (EE) Taxol-stabilized microtubules prior to cosedimentation.  (FF-
HH) Pellet from cosedimentation of microtubules and antiGFP pulldown fraction. (FF) 
Microtubule signal.  (GG) GFP signal.  (HH) Image from merged red-green channels.   
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4.12  FERM Overexpression in Tetrahymena thermophila  
Expression of GFP-FERM and GFP-FERM truncations was initiated by addition 
of 0.1- 0.5 µg/ml cadmium chloride to cultures of transformed cells.  GFP fluorescence 
was detected within 2-3 hours after addition of cadmium.  Transformed cells that over-
expressed GFP-fusion proteins exhibited significantly longer doubling times than wild-
type cells.  For example, at 0.1 µg/ml cadmium chloride the doubling time for the GFP-
FERM strain was 6.8 + 2.3 hours in contrast to 3.1 + 1.1 hours for wild-type control cells.  
Cadmium chloride concentrations greater than 0.1 µg/ml induced longer doubling times.  
At 1.0 µg/ml cadmium chloride there was significant cell death, and exponential growth 
was not achieved. Lysates from strains that over-expressed GFP-FERM, GFP-FERM-T1, 
or GFP-FERM-T2 were analyzed on immunoblots probed with GFP antibody, which 
detected GFP-fusion polypeptides at 80 kDa, 64 kDa, and 45 kDa, respectively (Fig. 7A).  
GFP-fusion polypeptides were not detected in lysate from a strain over-expressing GFP 
alone. 
Fig. 8.   
 
Fig 8. Immunoprecipitation (IP) and Immunoblot analysis of GFP-FERM, and 
GFP-FERM truncations overexpressing cells. (A)  Immunoblots of whole cell lysate from 
GFP-fusion strains.  Blots were probed with mouse anti-GFP.  Lane 1: GFP-FERM. The 
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fusion protein is 80 kDa.  Lane 2: GFP-FERM-T1. The fusion protein is 64 kDa.  Lane 3: 
GFP-FERM-T2.  The fusion protein is 45 kDa. (B) SDS-PAGE of anti-actin 
immunoprecipitation pellets (IP).  Gels were stained with Coomassie Blue.  Lane 1: Gel 
of anti-actin IP from GFP-FERM.  Lane 2: Gel of anti-actin IP from GFP-FERM-T1.  
Lane 3: Gel of anti-actin IP from GFP-FERM-T2.  Lane 4: Gel of anti-actin IP from GFP 
alone.  Lane 5: Gel of rabbit non-immune serum precipitate from GFP-FERM. (C) 
Immunoblots of anti-actin IPs.  All blots were probed with anti-GFP. 
Lane 1: Blot of anti-actin IP from GFP-FERM.  The fusion protein is 80 kDa.  
Lane 2: Blot of anti-actin IP from GFP-FERM-T1.  The fusion protein is 64 kDa.  Lane 
3: Blot of anti-actin IP from GFP-FERM-T2.  The major band is at 45 kDa.  Lane 4: Blot 
of anti-actin IP from cells expressing GFP alone.  Lane 5: Blot of rabbit non-immune 
serum precipitate from GFP-FERM. (D) Immunoblots of anti-actin IPs.  All blots were 
probed with mouse anti-beta tubulin.  Tubulin is 55 kDa in each lane.  Lane 1: Blot of 
anti-actin IP from GFP-FERM.  Lane 2: Blot of anti-actin IP from GFP-FERM-T1.  Lane 
3: Blot of anti-actin IP from GFP-FERM-T2.  Lane 4: Blot of anti-actin IP from GFP 
alone. 
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4.13 Antiactin Antibody Coprecipitates GFP-FERM 
To provide further evidence that FERM interacts with actin and tubulin in vivo, 
non-denatured lysate from each strain expressing a GFP-fusion polypeptide was 
processed for immunoprecipitation with rabbit anti-actin (Fig. 8B).  Actin antibody co-
precipitated GFP-fusion polypeptides (Fig. 8C) and tubulin (Fig. 8D).  Specifically, the 
immunoprecipitation (IP) pellets contained GFP-fusion polypeptides at 80 kDa, 64 kDa, 
and 45 kDa from strains expressing respectively, GFP-FERM, GFP-FERM-T1, and GFP-
FERM-T2 (Fig. 8C).  The IP pellets also contained actin and Myo1 (not shown).  Two 
control experiments were performed to rule out non-specific binding of GFP to actin and 
other proteins.  In one control experiment, an anti-actin IP pellet was prepared from cells 
expressing GFP alone and analyzed on an immunoblot probed with anti-GFP, which did 
not detect GFP (Fig. 8C).  In another control experiment, GFP was not detected on 
immunoblots of precipitation pellets obtained with non-immune serum (Fig. 8C).  
4.14 Antiactin Immunoprecipitation Pellets Contain GFP-FERM Fusions 
That Interact With f-Actin and Microtubules 
 IP pellets were used in co-sedimentation assays with either exogenous F-actin or 
exogenous microtubules.  F-actin and microtubules were randomly distributed prior to 
use in the assays (Fig. 9A, E).  Examination of the pellets from low speed centrifugation 
revealed co-localization of red and green fluorescence in aggregates of exogenous F-actin 
(Fig. 9B-D).  In parallel assays with exogenous microtubules, examination of co-
sedimentation pellets revealed co-localization of red and green fluorescence in aggregates 
of exogenous microtubules (Fig. 9F-H).  To determine whether exogenous actin filaments 
affect microtubule aggregation, a co-sedimentation assay was performed with a mixture 
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of unlabeled F-actin, rhodamine-labeled microtubules, and IP pellet.  Addition of actin 
filaments did not appear to affect aggregation of microtubules (Fig. 9G-H).  In the 
presence of GFP alone, actin filaments and microtubules did not sediment at low speed 
centrifugation.  
Fig. 9.  
 
Fig.  9. Co-sedimentation assays with anti-actin immunoprecipitation pellets from 
GFP-FERM and GFP-FERM truncations.  Magnification Bar = 5 µm.   (A) Phalloidin-
labeled muscle actin filaments prior to co-sedimentation.  (B-D) Pellets from co-
sedimentation of exogenous F-actin (red) and GFP-fusion polypeptides (green).  Merged 
green and red fluorescence images are shown.  (B) GFP-FERM and F-actin.  (C) GFP-
FERM-T1 and F-actin.  (D) GFP-FERM-T2 and F-actin.  (E) Taxol-stabilized 
microtubules prior to co-sedimentation.  (F-H) Pellets from co-sedimentation of 
exogenous microtubules (red) and GFP-fusion polypeptides (green).  Merged green and 
red fluorescence images are shown. (F) GFP-FERM and microtubules. (G-H) GFP-
FERM, microtubules, and unlabeled muscle actin filaments. 
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4.15  Cosedimentation Assays of FERM With f-Actin or Microtubules  
For cosedimentation essays of GFP-FERM and F-actin and microtubules, F-actin 
and microtubules were randomly distributed prior to use in the assay (Fig. 10A, D, G).  
Examination of pellets from co-sedimentation of actin filaments and GFP-fusion extracts 
revealed co-localization of red and green fluorescence in aggregates of actin filaments in 
the presence and absence of added ATP (Fig. 10B-C).  In a parallel experiment, 
examination of pellets from co-sedimentation of microtubules and GFP fusion extracts 
revealed co-localization of red and green fluorescence in aggregates of microtubules (Fig. 
10E-F).   A control experiment used actin filaments in the presence of 10 mM Mg-ATP 
and an extract from cells that expressed GFP alone.  Examination of the pellet from the 
control co-sedimentation assay did not detect co-localization of red and green 
fluorescence as shown in merged red and green images (Fig. 10H-I). 
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Fig. 10.  
 
Fig 10. Cosedimentation assays with whole cell extracts of GFP-FERM 
overexpressing cells.  Magnification Bar = 5 µm. Merged green and red fluorescence 
images are shown. (A) Phalloidin-labeled muscle actin filaments prior to co-
sedimentation.  (B-C)  Pellets from co-sedimentation of exogenous F-actin (red) and 
extract from cells expressing GFP-FERM. (B) F-actin and GFP-FERM in the presence of 
10 mM ATP.  (C) F-actin and GFP-FERM in the absence of added nucleotide. (D) Taxol-
stabilized microtubules prior to co-sedimentation.  (E-F)    Pellet from co-sedimentation 
of exogenous microtubules (red) and extract from cells expressing GFP-FERM.  Both 
 40 
images are from the same co-sedimentation pellet.  (G) Phalloidin-labeled muscle actin 
filaments prior to co-sedimentation.  (H-I) Pellet from co-sedimentation of exogenous F-
actin (red) and extract (10 mM ATP added) from cells expressing GFP alone.  The red 
channel image is shown in (H) and the merged green and red image is shown in (I). 
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Chapter 5 MyTH4 and FERM have distinct functions in Myo1 
5.1 GFP-MyTH4 Localizes to Myo1 Targets but Predominately in the 
Nucleus  
Cells overexpressing GFP-MyTH4 were challenged with red fluorescent beads as 
a marker for phagosomes and vitally stained with DAPI prior to confocal microscopy.  
GFP-MyTH4 localized to the macronucleus, micronucleus, phagosomes, and cytosol 
puncta (Fig. 11).  To determine whether GFP-MyTH4 colocalizes with endogenous 
Myo1, overexpressing cells were challenged with blue fluorescent beads as a marker for  
phagosomes and immunostained with antiMyo1.  Endogenous Myo1 colocalized with 
GFP-MyTH4 to phagosomes (Figs. 11G-11I).  To further investigate colocalization of 
GFP MyTH4, isolated nuclei from overexpressing cells were immunostained with 
antiMyo1 and antiactin.  In a previous report on immunolocalization of Myo1, isolated 
nuclei were fixed with an ethanol-triton fixative (Hosein and Gavin, 2007).  In the present 
study, we found that paraformaldehyde fixation revealed significant localization of 
antiMyo1 and antiactin within the macronucleus.  Both antibodies colocalized with GFP-
MyTH4 to tubular or filament-like structures within the nucleus and puncta at the nuclear 
periphery (Figs. 11M-11K).  Overexpressed GFP alone did not localize but accumulated 
nonspecifically in the cytosol.   
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Fig. 11.  
 
Fig. 11. Confocal images of GFP-MyTH4 localization.  (A-F) Localization of 
GFP-MyTH4 in living Tetrahymena.  Cells were stained with DAPI and imaged 
approximately 6 hours after initiation of GFP overexpression.  Each cell was separately 
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imaged with green, blue, and merged green-blue channels.  Macronucleus (n). 
Micronucleus (arrowheads).  (A-C) Scale bar =3.7 µm.  The anterior end of the cell is on 
the right side of each image. This cell was challenged with fluorescent beads (yellow 
fluorescence). (A) GFP signal. (B) DAPI signal. Numerous nuclear fragments are present 
in the cytosol.  (C) Image from merged green-blue channels.  (D-F) Scale bar =3.7 µm.  
This cell was not challenged with fluorescent beads.  (D) GFP signal. (E) DAPI signal.  
Numerous nuclear fragments are present in the cytosol.  (F) Image from merged green-
blue channels. (G-I) Immunofluorescence localization of Myo1 in cells overexpressing 
GFP-MyTH4.  Cells were challenged with blue fluorescent beads.  Scale bar = 3.7 µm.  
The anterior end of the cell is at the top of each image.  (G) Image from merged green 
and blue channels. (H) Red channel antiMyo1 signal.  (I) Image from merged green-red 
channels.  (J-L) Scale bar =6 µm.  Isolated nuclei from GFP-MyTH4.  Arrowheads locate 
the micronucleus.  (J) GFP signal. (K) DAPI signal.  (L) Image from merged green-blue 
channels.  (M-R) Scale bar =xx µm.  Immunofluorescence localization of Myo1 and actin 
in isolated nuclei from cells overexpressing GFP-MyTH4.  (M) GFP signal. (N) Red 
channel antiMyo1 signal.  (O) Image from merged green-red channels.  (P) GFP signal. 
(Q) Red channel antiactin signal.  (R) Image from merged green-red channels. 
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5.2 GFP-FERM Fusions Localize to Myo1 Targets but Predominately in the 
Cytosol 
 To determine whether FERM or truncations of FERM localize to Myo1 targets, 
cells expressing GFP-fusions were observed with confocal microscopy (Fig. 12, Table 1).  
Microscopy of living cells that had been challenged with fluorescent beads revealed 
localization of GFP-FERM to phagosomes, which often formed confluent aggregates 
resulting in large patches of fluorescence (Fig. 12A).  GFP-FERM localized to vacuoles 
and puncta within nucleoplasm (Fig. 12B-C, 12D, 12F).  Localization of GFP-FERM to 
microtubule and actin filament sites within the cytoskeleton is demonstrated by the 
fluorescent, crescent-shaped oral apparatus at the anterior of the cell (Fig. 12I-J), anterior 
to posterior fluorescent rows of basal bodies (Fig. 12I-P), and transverse fluorescent 
fibers between rows of basal bodies (Fig. 12N).  Phagosomes and puncta associated with 
the anterior to posterior alignment of basal bodies (Fig. 12I-P).  The puncta were often 
DAPI-positive (Fig. 12I-J).  Localization of GFP-FERM to cilia was not observed.  
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Fig 12.  
 
 Fig. 12. 
Localization of GFP-FERM in living Tetrahymena.  Magnification Bar =3.7 µm.  
Fluorescent beads are yellow, n = nucleus.  (A)  A cell challenged with fluorescent beads.  
Cells immobilized in agarose frequently become spherical.  (B-C)  Images from a x-z 
series through a cell that had been challenged with fluorescent beads.  Phagosomes 
localized to the nucleus.  (D)  A cell challenged with fluorescent beads and stained with 
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DAPI (blue fluorescence) to reveal the nucleus.  (E-H)  Images from a x-z series.  This 
cell was not challenged with fluorescent beads.  The intense fluorescence is from densely 
packed phagosomes.  Vacuoles and puncta (F) localized to the nucleus.  The oral 
apparatus (G-H) is the crescent-shaped fluorescent structure at the anterior of the cell.  (I-
L) Images from a x-z series through a cell challenged with fluorescent beads and stained 
with DAPI.  The anterior to posterior alignment of basal bodies and the crescent-shaped 
oral structure (I-J) at the anterior of the cell are seen in relationship to bead-containing 
phagosomes.  GFP-fluorescent puncta (I-J) were often DAPI-positive.  (M-P) Images 
from a x-z series through a cell challenged with fluorescent beads.  The cell shows the 
association of phagosomes with the anterior to posterior alignment of basal bodies. (N) 
GFP-FERM localized to transverse fibers (arrowheads) extending between rows of basal 
bodies.  
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5.3 GFP-MyTH4 Affects Division of the Macronucleus 
Wild type Tetrahymena contains one macronucleus and one micronucleus.  In 
cells overexpressing GFP-MyTH4, approximately 4% of a population was 
bimacronucleate, and many cells contained abundant macronuclear fragments (Figs. 5A-
5C).  Numerous DAPI-positive puncta accumulate at the cell surface (Fig. 5E).  In some 
overexpressing cells, GFP-MyTH4 and DAPI colocalized to the central region of the 
nucleus, whereas the periphery of the nucleus did not show GFP colocalization (Figs. 5D-
5F).   
Fig. 13.   
 
Fig. 13.  Confocal images.  Localization of GFP-MyTH4 in living Tetrahymena.  
Cells were stained with DAPI and imaged approximately 6 hours after initiation of GFP 
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overexpression.  Each cell was separately imaged with green, blue, and merged green-
blue channels.  Macronucleus (n). Micronucleus (arrowheads). (A-C) Scale bar =3.7 µm.  
The anterior end of the cell is at the top of each image. (A) GFP signal. (B) DAPI signal.  
(C) Image from merged green-blue channels. (D-F) Scale bar =3.7 µm.  The anterior end 
of the cell is at the top of each image. (D) GFP signal. (E) DAPI signal.  (F) Image from 
merged green-blue channels. 
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5.4 GFP-MyTH4 Affects the Organization of the Intramacronuclear 
Microtubule Array and Elongation of the Macronucleus 
Clustal alignments indicated a putative tubulin-binding site within MyTH4 (Fig. 
2B).  Therefore, the strong targeting of GFP-MyTH4 to the macronucleus and the 
occurrence of bimacronucleated cells led us to investigate the effect of overexpression on 
amitosis of the macronucleus with special focus on intranuclear microtubules.  The 
organization of the intranuclear microtubules has been extensively investigated with 
transmission electron microscopy (Williams and Williams, 1976) and 
immunofluorescence microscopy (Fujiu and Numata, 2000).  In amitosis, intranuclear 
microtubules that are initially random become oriented into an array parallel to the long 
axis of the cell (Fujiu and Numata, 2000; Williams and Williams, 1976).  Elongation of 
the macronucleus is accompanied by elongation of the parallel array of intranuclear 
microtubules (Fujiu and Numata, 2000; Williams and Williams, 1976). 
  In the current study, antitubulin was used to immunostain the microtubule array 
and provided the basis for analyzing the effect of overexpression on the progression of 
microtubule elongation and nuclear elongation during amitosis (Figs. 14, 15).  GFP-
MyTH4 colocalized with antitubulin to intramacronuclear microtubules (Fig. 15A).  A 
population of cells was monitored over a 12-hr period following initiation of GFP-
MyTH4 overexpression.  Six hours after initiation of overexpression, 80% of the cells 
were in stage I of amitosis in which intranuclear microtubules were assembled but not 
organized into a parallel array (Figs. 14, 15A, 15E).  The microtubules were often thick 
bundles and did not appear to be affected by a 30-min exposure to nocodazole, which 
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depolymerized cytoplasmic microtubules (Figs. 15I-15L).  Six hours after initiation of 
overexpression of GFP-MyTH4, only 5% of the cells had advanced to early stage II of 
macronuclear division in which intranuclear microtubules were partially organized into a 
parallel array (Figs. 14, 15M, 15Q).  The orientation of the microtubule array often did 
not appear to be parallel to the long axis of the cell and many of the microtubules within 
the array did not appear to extend to the perimeter of the nucleus (Fig. 15M).   
Monitoring the population of overexpressing cells for an additional 6-hr period revealed 
that the early stage II nuclei and the parallel array of intranuclear microtubules did not 
achieve full elongation (Fig. 14).  Constriction of partially-elongated stage II nuclei (Fig. 
16M) and cytokinesis in the absence of an apparent amitosis (Fig. 15M) led to 
uncoupling of macronuclear division and cytokinesis.  In contrast, a wild type population 
displayed a normal progression of amitosis over a 12-hr interval (Fig. 14).  Figs. 15U-
15W show an early stage in the formation of the intranuclear microtubule array in a wild 
type cell.  In the wild type image, numerous microtubules were parallel to the long axis of 
the cell and extended anteriorly and posteriorly from the array to the perimeter of the 
nucleus.  In the central region of this nucleus, the microtubules have not fully formed the 
parallel organization.  The overexpression data for GFP-MyTH4 are consistent with the 
MYO1 knockout phenotype in which the normal progression of amitosis fails to occur in 
some cells (Williams et al., 2000).  Mitosis of the micronucleus appeared to be unaffected 
in the overexpression phenotype.  Cell density gradually declined over a 12-hour period 
of overexpression.  
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Fig. 14.  
 
Fig. 14.  Nuclear division (amitosis) in Tetrahymena thermophila.  Stages of 
amitosis (I-V) are diagrammed with emphasis on the orientation and elongation of the 
microtubule array and elongation of the macronucleus as observed in wild type cells 
immunostained with antitubulin.  The distribution (%) of nuclei in various stages of 
amitosis is recorded for wild type and MyTH4 overexpression cells.  For the 
overexpression phenotype, n = 320 cells analyzed.  For wild type (WT) n = 210 cells 
analyzed.  For cells expressing GFP alone (GFP) n = 88 cells analyzed.  Stage 0: The 
interphase nucleus (dark circle).  Stage I: Nucleus with random microtubules.  Stage II: 
Elongation of the nucleus and the microtubule array.  The microtubule array extends to 
the perimeter of the macronucleus and is parallel to the long axis of the cell.  Stage III: 
Intranuclear microtubules elongate.  Cytoplasmic microtubules that connect the nuclear 
envelope with the cell periphery are not shown.  Stage IV: Constriction of the 
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macronucleus at its midpoint.  Stage V: Completion of macronuclear separation.  
Diagram redrawn from Williams et al. (2000).   
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Fig. 15.   
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Fig. 15.  Immunofluorescence localization of tubulin in GFP-MyTH4 
overexpressing cells. Cells were fixed 6-hrs after induction of GFP expression.  Each cell 
was separately imaged with green, red, and blue channels and with merged green-red 
channels.  The anterior end of the cell is at the top of each image.  The white lines allow 
identification of the long axis of the cell.  However, in each image the cell is magnified 
larger than the boundary indicated by the white lines. (A-T) Cells expressing GFP-
MyTH4. (A-D) Scale bar =1.5 µm. Macronucleus in Stage I of nuclear division.  (A) 
Antitubulin signal. Intramacronuclear microtubules are evident throughout the nucleus.  
Representative microtubules are identified by arrows.  Tubulin localization to the cortex 
is not evident in this optical section. (B) GFP signal. (C) Image from merged green-red 
channels.  GFP-MyTH4 and antitubulin show significant colocalization.  (D) DAPI 
signal.  (E-H) Scale bar =5.5 µm.   Macronucleus is in stage I.  A division furrow 
(arrowheads) has formed and cytokinesis will produce an amacronucleate subcell.  (E) 
Antitubulin signal.  Microtubules appear as thick bundles (arrows). (F) GFP signal. (G) 
Image from merged green-red channels. (H) DAPI signal.  Numerous DAPI-positive 
puncta accumulate at the cell surface.  (I-L) Scale bar =3.7 µm.  Macronucleus in stage 1 
in a cell treated with nocodazole.  (I). Antitubulin signal Microtubules appear as thick 
bundles.  (J) GFP signal.  (K) Image from merged green-red channels.  (L) DAPI signal.  
(M-P) Scale bar =1.5 µm.  Macronucleus in stage II of nuclear division.  (M) Antitubulin 
signal.  Representative microtubules within the intramacronuclear microtubule array are 
identified by arrows.  (N) GFP signal. (O) Image from merged green-red channels.  GFP-
MyTH4 and antitubulin show significant colocalization.  (P) DAPI signal.  Macronuclear 
fragments are abundant throughout the cytosol.  (Q-T) Scale bar =1.5 µm.   
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Macronucleus is in stage II.  (Q) Antitubulin signal.  Representative microtubules within 
the intramacronuclear microtubule array are identified by arrows.  (R) GFP signal. (S) 
Image from merged green-red channels. (T) DAPI signal. (U-X) Scale bar =1.5 µm.   
Optical sections through an early stage II macronucleus in a wild type cell. (U-W) 
Antitubulin signal.  (X) DAPI signal. 
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5.5 Overexpression of a Truncated MyTH4  
To determine whether deletion of the putative tubulin binding site within MyTH4 
affected the association of MyTH4 with tubulin, a truncated MyTH4 domain that 
eliminated the putative tubulin binding motif was fused with a GFP construct and used to 
transform Tetrahymena. However, this construct induced death upon induction, and data 
was not able to be collected.  
5.6 GFP-FERM Affects the Trafficking of Phagosomes and Membrane 
Recycling at the Cytoproct  
In Tetrahymena, phagosomes are formed in the feeding structure known as the 
oral apparatus at the anterior portion of the cell. They are processed into digestive feeding 
structures by fusion with lysosomes while transported to the posterior region of the cell. 
The membrane material is recycled in the posterior region of the cell by an organelle 
known as the cytoproct. The distribution of fluorescence from GFP-FERM is consistent 
with localization to the basal body-associated filament complex and transverse 
microtubule bands (Fig. 12N). In the overexpression of GFP-FERM truncations, 
phagosomes accumulate at the posterior region of the cell (Fig 16) and it seems that this 
caused by the overexpression of GFP-FERM truncations. Localization of MyTH4 (Fig. 
11),  truncated FERM domains containing either the FERM N-terminus region (Fig. 16A-
D) or the FERM C-terminus region (Fig. 16E-H) was strikingly different from the 
localization of GFP-FERM (Table 1, Fig. 12).  GFP-MyTH4 localizes to the nucleus. 
Truncated FERM domains localized to phagosomes but not to the cytoskeleton or the 
nucleus.  Confluent aggregates of phagosomes were often located in the posterior region 
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of cells over-expressing truncated FERM domains.  Cells expressing GFP without FERM 
displayed un-localized fluorescence throughout the cytosol.    
Fig 16.   
 
 Fig 16.  Localization of truncated GFP-FERM domains in living 
Tetrahymena challenged with fluorescent beads (yellow).  Magnification Bar =3.7 µm. 
(A-D) Localization of GFP-FERM-T1 containing the N-terminal region of FERM.  
Images from a x-z series.    (E-H) Localization of GFP-FERM-T2 containing the C-
terminal region of FERM.  Images from a x-z series. 
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Chapter 6 Discussion for MyTH4 and FERM 
 
6.1 Overexpression of GFP Fusions 
 Expression of Tetrahymena genes in heterologous hosts such as bacteria is highly 
problematic due to the unusual codon usage in Tetrahymena (Horowitz and Gorovsky, 
1985) in which TAA and TAG code for glutamine.  Myo1 MyTH4 contains 7 and FERM 
contains 49 TAA or TAG stop codon triplets.  Therefore, in this study, the Tetrahymena 
expression system is the method of choice for investigating interactions between MyTH4 
and FERM and cytoskeleton proteins.  Homologous-host expression allows investigation 
of endogenous binding partners whether direct or indirect. 
6.2 MyTH4 Interacts With Intranuclear Tubulin and Actin  
Antiactin coprecipitates GFP-MyTH4, tubulin, actin, and Myo1.  AntiGFP 
affinity pulls down GFP-MyTH4, tubulin, and actin.  These two experimental 
observations are strong indications that GFP-MyTH4 interacts with tubulin and actin.  
However, presence of additional proteins in both the IP and the antiGFP pulldown makes 
it difficult to conclude whether the binding of actin and tubulin is direct or indirect.  In 
the cosedimentation experiments, MyTH4 associates with crosslinked F-actin and 
crosslinked microtubules.  If there were direct binding of tubulin and actin to MyTH4, 
crosslinking of the polymers could be problematic because Clustal W alignments suggest 
only a single putative tubulin binding site and one actin binding site within MyTH4.  
Therefore, if the observed crosslinking were a function of direct binding to MyTH4, 
interaction between two MyTH4 domains would be required.  Studies of FERM-FERM 
interactions indicate MyTH4-MyTH4 interactions are at least feasible.  ERM family 
proteins, e.g., ezrin are known to exist as monomers and dimers, and two associated 
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FERM/ C-ERMADs (C-terminal ERM association domain) have been proposed to exist 
within the dimer (Chambers and Bretscher, 2005; Bretscher et al., 1995).  Studies of 
radixin FERM dimers identify a sequence that is proposed as the site involved in 
dimerization of FERM (Kitano et al. 2006).  Interestingly, the radixin sequence loosely 
matches a sequence in Myo1 FERM (Gotesman et al., 2010) and in Myo1 MyTH4 (Fig. 
2).  In the light of these studies of ERM proteins, it is therefore intriguing to speculate 
that for Myo1 both FERM and MyTH4 could form dimers.  Formation of MyTH4 dimers 
or dimerization of MyTH4 with any of the five Tetrahymena myosins that contain 
MyTH4 domains could be sufficient for crosslinking either microtubules or F-actin.  
Crosslinking of F-actin occurs in the presence and absence of added nucleotide and is 
therefore independent of the actin-binding site in the myosin motor domain.   
6.3 MyTH4 Localizes to Myo1 Targets and Affects Myo1 Function 
  Two important observations indicate MyTH4 targets the same sites as Myo1 and 
affects Myo1 function.  GFP-MyTH4 and Myo1 colocalize to the interior to the nucleus, 
and the GFP-MyTH4 overexpression phenotype partially mimics the MYO1 knockout 
phenotype.  In both overexpressing cells and MYO1-knockout cells, macronuclear 
elongation fails to properly occur, cytokinesis and division of the macronucleus are 
uncoupled, and consequently, division progeny often contain two macronuclei or no 
macronucleus.  
6.4 Elongation and Constriction of the Macronucleus 
The precise role of intranuclear microtubules in elongation and constriction of the 
nucleus is not fully understood.  It is unclear whether polymerization of microtubules or 
sliding of microtubules is a driving force for nuclear elongation.  Alternatively, 
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elongation of microtubules could depend upon elongation of the nucleus.  Two studies 
specifically connect tubulin with effects on nuclear elongation and constriction.  In one 
study, a mutation in a beta tubulin gene is associated with failure of macronuclear 
elongation and constriction resulting in amacronucleated cells at cytokinesis (Smith et al., 
2004).  Another study suggests that force production for elongation and constriction does 
not depend entirely on microtubule dynamics.  Macronuclei in colchicine-treated cells 
initiate the elongation process in the absence of intranuclear microtubules, but the nuclei 
do not fully elongate and do not constrict into two subnuclei (Williams and Williams, 
1976).  Application of colchicine to fully elongated macronuclei does not prevent 
constriction into subnuclei. 
 Elongation and constriction of the macronucleus could also involve actin, perhaps 
in association with microtubules.  Antibodies against actin and Myo1p colocalize to the 
the macronucleus.  Knockout of MYO1 severely impairs elongation of the nucleus during 
nuclear division and is indirect evidence that actin is involved in elongation (Williams et 
al., 2000).  Interestingly, knockout of an actin gene (ACT1) in Tetrahymena does not 
appear to affect cytokinesis or nuclear division (Williams et al., 2006).  However, 
overexpression of ACT1 leads to failure of macronuclear elongation (Hosein et al., 2003). 
6.5 Overexpression of GFP-MyTH4 Affects Organization of the MT Array, 
a Possible Driving Force for Elongation of the Macronucleus 
During a 12-hr period of overexpression of GFP-MyTH4, more than 90% of the 
cells are permanently arrested in stage I of amitosis, and the intranuclear microtubules 
fail to become organized into a parallel array.  The microtubules appear as thick bundles 
suggesting a highly crosslinked structure.  Interestingly, nocodazole did not appear to 
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affect the bundle-like appearance of intranuclear microtubules, perhaps due to extensive 
crosslinking of the microtubules.  Five percent of overexpressing cells organize the 
intranuclear microtubules into a parallel array, but the microtubules and nucleus fail to 
achieve full elongation.  Partially-elongated nuclei apparently constrict into two 
subnuclei that remain in one subcell at cytokinesis thereby producing bimacronucleate 
and amacronucleate subcells and uncoupling nuclear division and cytokinesis (Fig. 13G-
13I).  Additionally, overexpression appears to lead to an aberrant orientation of the 
microtubule array, which is not parallel to the long axis of the cell (Fig. 14E).  Failure of 
intramacronuclear microtubules to form parallel arrays, failure of the macronucleus to 
elongate, and aberrant constriction of the macronucleus indicate MyTH4 interaction with 
microtubules affects microtubule organization and elongation of the macronucleus.  One 
could argue that elongation of the macronucleus requires a parallel array of microtubules 
and that polymerization of microtubules within the array could be a driving force for 
nuclear elongation. 
6.6 GFP-MyTH4 Affects Myo1 Function 
Several observations suggest that GFP-MyTH4 specifically contributes to Myo1 
function and that it is unlikely the GFP-MyTH4 phenotype is a nonspecific effect of 
overexpressed GFP.  GFP-MyTH4 and Myo1 colocalize, and the overexpression 
phenotype mimics the knockout phenotype with respect to elongation of the 
macronucleus and uncoupling of macronuclear division and cytokinesis.  GFP-MyTH4 
specifically targets intramacronuclear microtubules and is not randomly accumulated in 
the nucleus.  Targeting of GFP-MyTH4 to intranuclear microtubules could involve a 
specific posttranslational modification of these microtubules (Gaertig and Wloga, 2008; 
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Hammonda et al., 2008; Wloga et al., 2008).  Furthermore, overexpression of other GFP-
tagged, truncated tail domains does not lead to accumulation of GFP in the nucleus.  For 
example, overexpressed truncated GFP-FERM domains comparable in molecular mass to 
GFP-MyTH4, do not localize to the nucleus (Gotesman et al., 2010).  Interestingly, GFP-
tagged MyTH4 from Myo9 (amino acids 1049 through 1226), another Tetrahymena 
myosin, does not localize and is distributed diffusely throughout the cytosol (unpublished 
data).  We argue that in light of these various observations, overexpresssed MyTH4 
contributes to Myo1 function. 
6.7  Proposed Model for Interaction Between MyTH4 and Microtubules 
A proposed model for interaction between MyTH4 and microtubules is shown in 
Fig. 17. The model is based on a proposed dimerization of MyTH4 in a manner suggested 
by the reported dimerization of FERM (Kitano et al., 2008) and is consistent with either 
polymerization of microtubules or sliding of microtubules as the driving force for 
elongation of the macronucleus.  MyTH4 is proposed to bind to the plus end of 
microtubules and proposed MyTH4 dimers could crosslink microtubules, converting 
random microtubules into an array that is oriented parallel to the long axis of the cell.  In 
overexpressing cells, the orientation of the microtubule array frequently is not parallel to 
the long axis of the cell.  Overabundance of MyTH4 could lead to excessively 
crosslinked microtubules, which would not form parallel arrays.  Another prediction of 
the model is that overabundance of MyTH4 accumulates at the plus ends of microtubules 
and could create a cap that could prevent elongation of microtubules and thereby 
eliminate the force of polymerization required for elongation of the nucleus.  
Cosedimentation assays are consistent with the proposed model.  GFP-MyTH4 
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cosediments with crosslinked microtubules in which MyTH4 appears to be localized at 
one end a microtubule (Fig. 7L, Inset).  Colocalization of GFP-MyTH4 and antitubulin is 
also consistent with the proposed model.  The central region of the microtubule array 
displays the most prominent colocalization of GFP-MyTH4 and antitubulin.  
Microtubules extend from this region of intense colocalization (Figs. 15G, 15K).  The 
proposed model, at best, could account for only part of the machinery required for 
elongation of the nucleus.  Studies of microtubule inhibitory drugs indicate that force 
production for elongation of the nucleus does not depend entirely on microtubule 
dynamics (Williams and Williams, 1976). 
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Fig. 17.  
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Fig. 17.  A proposed model for the role of MyTH4 in the organization of a microtubule 
array.   Green = MyTH4, Red = crosslinked microtubules, Yellow = Overlap between 
MyTH4 and microtubules.  Myo1p through its MyTH4 domain is proposed to bind to the 
plus end of microtubules and crosslink the microtubules, which form an array oriented 
parallel to the long axis of the cell.  Elongation of the microtubule array is accompanied 
by elongation of the nucleus as shown at the top of Fig. 16.  Excess (overexpression) of 
MyTH4 is proposed to create a cap at the microtubule plus end, and consequently, the 
microtubules do not reach the perimeter of the nucleus and the orientation of the array 
often appears aberrant (Image at bottom of Fig. 15).  
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6.8 Analysis of GFP-FERM Overexpression in Tetrahymena thermophila 
Immunoblot analysis confirms the predicted molecular mass for the GFP-fusion 
polypeptides (Fig. 7).  Some fusion polypeptides from strain GFP-FERM-T2 are higher 
in molecular mass than the predicted value, a probable indication of post-translational 
modification.  The three transformed strains that overexpress FERM or a truncated 
FERM have apparently different physiological states as indicated by the large variation in 
generation times and the significant cell death in the strains expressing a truncated 
FERM.  The three strains could have perturbations in actin and tubulin dynamics.  
Variations in gel profiles of IP pellets from the three strains most likely reflect the 
apparent physiological state of each strain.   
6.9 Myo1 FERM interacts with actin filaments and microtubules. 
 Immunoprecipitation assays indicate Myo1 FERM interacts with actin and 
tubulin.  Actin antibody co-immunoprecipitates GFP-fusions and tubulin from lysate of 
strains that over-express GFP-fusions (Fig. 7C-D).  Actin antibody immunoprecipitates 
tubulin but not GFP from lysate of the strain expressing GFP alone (Fig. 7C-D).  
Therefore, it appears unlikely that GFP interacts non-specifically with proteins in IP 
pellets.  
 Co-sedimentation assays reveal that fluorescence from either actin filaments or 
microtubules co-localizes with GFP fluorescence in whole cell extracts (Fig. 9) and IP 
pellets (Fig. 10) from strains expressing GFP-fusions but not in cell extract from the 
strain expressing GFP alone (Fig. 7).  These two co-sedimentation assays provide strong 
evidence that Myo1 FERM interacts with both actin and tubulin and that the interactions 
are not attributable to non-specific binding of GFP.  Interactions with actin and tubulin 
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could be achieved through direct binding with FERM or through indirect binding 
involving accessory proteins that are associated with FERM.  SDS-PAGE analysis 
reveals several polypeptides in the anti-actin immunoprecipitation pellets consistent with 
numerous actin-binding and tubulin-binding proteins that are potential sites for indirect 
binding of actin and tubulin to FERM (Fig. 7B).  The two putative actin-binding and 
tubulin-binding sequences in FERM could cross-link and stabilize actin filaments and 
microtubules, respectively.  Each truncated GFP-FERM domain contains only one actin-
binding sequence and one tubulin binding sequence.  However, each truncated FERM 
contains a sequence motif for possible dimerization of FERM in vivo and in vitro.  
Endogenous Myo1 and other FERM-containing myosins could dimerize with over-
expressed FERM and contribute to cross-linking activity.  Addition of actin filaments to 
microtubule co-sedimentation assays does not appear to significantly enhance the 
aggregation of microtubules, an indication that FERM does not appear to influence direct 
interactions between actin filaments and microtubules. 
 Existence of ERM-like binding motifs in the FERM domain and other regions of 
Myo1 indicate this myosin could have functions that are independent of its actin-
dependent ATPase activity.  ERM-family proteins are inactive when intramolecular 
binding of FERM to the C-ERMAD masks binding sites within FERM (Pearson et al., 
2000).  Kitano et al. (2006) point out that in both ezrin and radixin, the KxxTIxVxxM 
motif overlaps with the actin-binding site and suggest that the motif is involved in 
regulation of actin binding.  One or both of the KxxTIxVxxM sequences in Myo1 FERM 
could be masking motifs that regulate accessibility of actin-and tubulin-binding sites.  
Interestingly, the KxxTIxVxxM motif in the C-terminal region of Myo1 FERM overlaps 
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with both the C-terminal actin-binding sequence and the C-terminal tubulin-binding 
sequence.  Another potential function of the KxxTIxVxxM motif could be intermolecular 
binding of FERM to form a Myo1 dimer in the absence of apparent coiled-coil domains 
in the Myo1 tail.  Dimerization of Myo1 could facilitate its motor activity on actin 
filaments.  A putative FERM binding motif (TKQRIDEFEAL) in the Myo1 motor 
domain could provide a site for interaction between FERM and the motor and effectively 
mask a binding site for a ligand that, in some way, is involved in regulation of motor 
activity.  Binding of FERM to the motor would require a conformational change such that 
the Myo1 tail would be bent against the motor.  Interestingly, studies of a class VII 
myosin reveal that in an ATP-dependent manner, the tail domain is bent against the 
motor domain and that deletion of a sub-domain within FERM eliminates bending (Yang 
et al., 2009).  
6.10 FERM is Involved in Localization of Myo1 
 Previous investigations of Myo1 and actin utilized over-expression of GFP-actin 
and immunostaining with a peptide antibody that detects the full-length Myo1 (Hosein et 
al., 2003, 2005; Hosein and Gavin, 2007).  GFP-actin localizes to the cytoskeleton and 
phagosomes.  The Myo1 peptide antibody localizes to phagosomes, vacuoles, and puncta 
within nucleoplasm, and weakly immunostains basal bodies within the cytoskeleton as 
evident in the peripheral immunolabeling of the cell in Fig. 2j and 2l of Hosein and Gavin 
(2007).  In the present study GFP-FERM localizes to the cytoskeleton, phagosomes, and 
both cytoplasmic and nuclear puncta (Fig. 12).  The punctate localization of Myo1 FERM 
to the nucleus is consistent with the apparent punctate nuclear localization of another 
class XIV myosin, Pfmyo-D in Plasmodium falciparum (Chaparro-Olaya et al., 2005).  
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GFP-labeled puncta in the cytosol were frequently DAPI-positive and therefore could be 
extruded chromatin from the macronucleus.  Wild type Tetrahymena frequently 
eliminates chromatin from the macronucleus (Cleffmann, 1980).  Even though the GFP-
FERM construct eliminates all of the Myo1 sequence N-terminus of FERM, the truncated 
tail localizes to the same targets as the full length Myo1.  This finding is a strong 
indication that FERM is significantly involved in localization of Myo1 to all of its known 
targets.   
 Localization of GFP-FERM to puncta and vacuoles within the nucleus indicates 
trafficking of vacuoles to the nucleus as previously reported (Hosein and Gavin, 2007). 
This highly unusual trafficking to the nucleus could involve a NLS associated with the 
vacuole membrane.  NLS-like sequences are revealed in an alignment of Myo1 FERM 
with the NLS (PPKKKRKVED) for Simian virus 40 large T antigen, and a recent study 
(Rahaman et al., 2008) demonstrates that the SV40 NLS can target proteins to the nucleus 
in Tetrahymena.  Localization of FERM to the nucleus is consistent with presence of 
NLS-like sequences in both the N-terminus and C-terminus regions of FERM.  Failure to 
observe localization of truncated FERM domains to the nucleus is an indication that 
nuclear localization of FERM requires interaction between N-terminus and C-terminus 
sequences within FERM.  How vacuoles interact with the nuclear envelope is unknown, 
but at least one experimental model involving liposomes should be noted.  ERM family 
proteins can induce reversible holes in liposomal membranes assembled from neutral and 
acidic phospholipids (Saitoh et al., 1998; Takeda et al., 2006).  Talin-induced holes in 
giant liposomes can allow entry of a spherical liposome larger than 1.0 µm (Saitoh et al., 
1998; Takeda et al., 2006).  Although it seems unlikely that perforation of cellular 
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membranes occurs in vivo, the liposome model at least raises the possibility that ERM 
family and ERM-like proteins function in reversible reorganization of membrane 
structure that could drastically alter traffic across the membrane. 
 Microtubules and actin filaments could mediate localization of FERM.  GFP-
FERM localizes to basal bodies but apparently not to cilia, and it is intriguing to suggest 
the possibility that FERM interacts with a post-translational modification such as tubulin 
glutamylation, which involves two enzymes that could modify different sites on tubulin 
in basal bodies and cilia (Gaertig and Wloga, 2008; Hammonda et al., 2008; Wloga et al., 
2008).  Truncated FERM domains contain either the N-terminus region or C-terminus 
region of FERM and only one tubulin-binding sequence and one actin-binding sequence.  
The truncated domains fail to localize to the nucleus and basal bodies (Fig. 13), possibly 
a reflection of reduced ability to interact with microtubules and actin filaments.  Although 
localization of FERM can apparently occur independent of other regions of Myo1, it is 
possible that redundancy of function within the tail domain could provide multiple 
regions that affect localization of Myo1 independent of its FERM domain.  That either 
the N-terminus region or the C-terminus region of FERM localizes to phagosomes 
indicates redundancy of function within the Myo1 tail domain.  
6.11 Phagosome Motility on Cortical Rows of Basal Bodies?  
 Phagosomes align along the anterior to posterior axis of Tetrahymena and move 
toward the posterior of the cell while maintaining the alignment (Hosein et al., 2005).  In 
MYO1 knockout, phagosomes are much less likely to be aligned, and their movement is 
random rather than directed toward the posterior of the cell (Hosein et al., 2005).  
Putative interaction of phagosomes with basal bodies and the directed nature of 
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phagosome motility could depend on transient attachments between phagosomes and 
basal body-associated structures within the cell cortex.  Cortical structures that could 
provide transient attachment sites for vacuoles include the actin-rich filament complex 
surrounding each basal body (Hoey and Gavin, 1992) and transverse microtubule bands 
extending between rows of basal bodies (Allen, 1967).  The distribution of fluorescence 
from GFP-FERM is consistent with localization to the basal body-associated filament 
complex and transverse microtubule bands (Fig. 12N). 
6.12 MyTH4 and FERM Have Overlapping and Distinct Roles in Myo1 
Function 
Coimmunoprecipitation, antibody pulldown, and cosedimentation assays indicate 
both MyTH4 and FERM interact with tubulin and actin (directly or indirectly), and 
therefore the two domains display overlapping functions.  Localization of MyTH4 and 
FERM is consistent with distinct functions for the two domains in Myo1p.  MyTH4, 
independent of FERM strongly targets intranuclear microtubules, whereas FERM, 
independent of MyTH4, localizes to the cytoskeleton.  Overexpressed N-terminus and C-
terminus truncated FERM domains do not localize to the cytoskeleton (Gotesman et al., 
2010).  Therefore, the entire FERM domain, independent of MyTH4, is a sufficient and 
required domain for localization to the cytoskeleton.  
 The contrast between phenotypes from overexpression of either MyTH4 or FERM 
is a further indication of distinct roles for the two domains.  Overexpression of GFP-
MyTH4 adversely affects organization and elongation of intramacronuclear microtubules, 
elongation of the macronucleus, and the coupling of nuclear and cytoplasmic division.  
Trafficking of phagosomes does not appear to be affected in the GFP-MyTH4 phenotype.  
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The GFP-MyTH4 overexpression phenotype is severe and over time becomes lethal, a 
likely consequence of overabundance of MyTH4 bound to targets of wild type Myo1.  In 
contrast to overexpression of GFP-MyTH4, cells overexpressing GFP-FERM do not 
appear to have abnormalities in elongation and constriction of macronuclei, but 
phagosomes abnormally accumulate at the membrane recycling site in the posterior end 
of cells overexpressing a C-terminus truncated FERM domain (Gotesman et al., 2010).   
 A summary of the distinct localization and roles for MyTH4 and FERM is shown 
in table 1.   
TABLE 1.  Localization of Myo1 MyTH4 and FERM 
 
Domain  Construct  Localization 
 
MyTH4  (GFP-MyTH4) intranuclear microtubules, phagosomes 
N-terminus MyTH4 (GFP-MyTH4T) expression is lethal 
FERM   (GFP-FERM)  phagosomes, cytoskeleton, nucleus 
N-terminus FERM (GFP-FERM-T1) phagosomes 
C-terminus FERM (GFP-FERM-T2) phagosomes 
 
 
Table 1. Localization of Myo1 MyTH4 and FERM
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Chapter 7 Concluding Summary 
 Five of the thirteen Tetrahymena thermophila myosins consist of a 
MyTH4/FERM domain that is common to human class VII, X, XV myosins, nematode 
class XII myosin, and the divergent Dictyostelium myosin, MyoG. The role of the 
MyTH4/FERM domains in the function of these myosins is poorly understood. This 
dissertation separates MyTH4 and FERM into separate domains to determine how each 
domain serves to function Myo1. We examined whether these domains have similar, 
overlapping or discrete roles in the function of Myo1.  
Biochemical evidence shows MyTH4 and FERM, to be similar. Each domain is 
pulled down by lowspeed centrifugation by exogenous f-actin or microtubules; implying 
that these domains act in a complex that crosslinks f-actin and microtubules, and possibly 
to each other.  Both domains are found in fractions that were separately co-
immunoprecipitated with antiactin. Those fractions were also enriched with tubulin. And 
those co-immunoprecipitated fractions that are enriched with GFP-Myo1 tail truncations 
retained both f-actin and microtubular crosslinking abilities.  
However, confocal Microscopy of GFP-MyTH4, GFP-FERM, and GFP-FERM 
truncations revealed that each domain localizes in a distinct pattern of Myo1 targets. 
GFP-MyTH4 localizes predominately to the nucleus, and colocalizes to intranuclear 
microtubules in conjunction to localizing to phagosomes. Whereas, GFP-FERM localizes 
to phagosomes, and sparsely to the nucleus as puncta.  And GFP-FERM truncations 
localize to phagosomes and the cytoskeleton. Phenotypic analysis of overexpression of 
distinct GFP-Myo1 truncations reveals that GFP-MyTH4 disrupts the transition from 
stage I to Stage II during amitosis in Tetrahymena, by affecting the crosslinking pattern 
 74 
of intranuclear microtubules. Whereas, overexpression of FERM affects phagosome 
trafficking and recycling at the cytoproct. 
Complete localization of FERM to Myo1 targets is consistent with a parallel study 
in which a Class VII Myosin (Myo7A) truncated for the second FERM domain in mice 
fails to localize to melanosomes, leading to hair bundle defects (Shwander et al., 2009). 
Also, MyoVIIa knockout in Dictyostelium discodium inhibits phagocytosis, possibly by 
disrupting phagosome trafficking (Titus, 1999; Tuxworth et al, 2001). Similarly, 
phagocytosis is affected in bovine pulmonary alveolar macrophages (PAMs) by 
inhibition of Myo10, a MyTH4/FERM myosin and expression of Myo10-headless 
truncations (Cox et a., 2002).  Therefore, the role of Myo1-FERM in affecting 
phagosome recycling, localizing to myo1 targets, and interacting with f-actin is consistent 
with current research in other FERM myosins. However Myo1-FERM interacting with 
microtubules is a novel finding of this work. 
Myo1 in Tetrahymena thermophila may associate with microtubules by the 
MyTH4/FERM region or by a novel region demonstrated by the ability of MyoVa (a non-
MyTH4/FERM myosin) to “randomly diffuse back and forth” on microtubule tracks (Ali 
et al., 2006). During nuclear division of Lecudina tuzetae, the nuclear envelope does not 
breakdown, microtubule polymerization may act as the “pushing force” to separate the 
dividing nucei in L. tuzetae (Kuriyama et al., 2005). If a similar process takes place in 
Tetrahymena, then overexpression of the GFP-MyTH4 can crosslink nuclear 
microtubules and thereby arrest nuclear division. The six Plasmodium falciparum class 
XIV myosins, PfmyoA-F, are differentially expressed in during malaria development and 
PFmyoD localizes to segregating nuclear material during the schizont phase of 
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development (Chaparro-Olaya et al, 2005). Accordingly, another class XIV myosin, 
Myo1, localizes to the nucleus and affects intranuclear microtubules during macronuclear 
elongation and is maximally expressed during conjugation. 
 It appears that MyTH4 and FERM domains have similar and overlapping roles in 
the function of Myo1. MyTH4 and FERM function in the crosslinking of f-actin, 
microtubules, and possibly the crosslinking of f-actin to microtubules. However, MyTH4 
and FERM are active in different regions of Tetrahymena. MyTH4 functions in the 
nucleus during the elongation of intranuclear microtubules at macronuclear division, 
whereas FERM functions in the cytosolic regions of the cell, at the cytoskeleton and 
phagosome and is involved in trafficking phagsomes from the oral apparatus to the 
cytoproct and in recycling of membrane material at the cytoproct. Therefore, MyTH4 and 
FERM have overlapping roles in the function of Myo1 in terms of association with actin 
and tubulin. However, MyTH4 localizes and functions in the nucleus and FERM 
localizes and functions in the cytosol and therefore, MyTH4 and FERM have distinct 
responsibilities in Myo1 function. Although many roles for myosin in the nucleus have 
been reported, the exact function of Myo1 in the Tetrahymena nucleus is unclear. But our 
speculation that Myo1 is involved in orienting intranuclear microtubules during 
macronuclear elongation is consistent with findings that the MyTH4 region of Myo10 in 
Xenopous oocytes orients spindle pole bodies during mitosis (Sandquist et al., 2009; 
Sandquist and Bement, 2010).  The results could provide new insight into the function of 
MyTH4 and FERM domains in myosins, kinesins, and non-motor proteins.   
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Chapter 8 Methods 
 
Materials and Methods: 
Creation of Overexpression Constructs 
All MYO1 and Myo1 sequences were accessed using accession code U87268.2 
from the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/). 
The physical characteristics were analyzed using the protparam tool at The ExPASy 
(Expert Protein Analysis System) proteomics server of the Swiss Institute of 
Bioinformatics (SIB) (http://www.expasy.ch/tools/protparam.html). Conserved domain 
database (CDD) (Marchler-Bauer and Bryant 2004; Marchler-Bauer A et al. 2005; 
Marchler-Bauer and et al. 2007), and Prosite (Hulo and et al., 2007) was used to model 
the updated sequence of Myo1. ClustalW (Kyoto University Bioinformatics Centers) 
alignment of the Myo1 sequence with calmodulin-binding sequence (reviews, Cheney, 
1992; Rhoads and Friedberg, 1997; Gillespie and Cyr, 2002,) the Dictyostelium talin 
actin-binding site (ABS), the Rattus MAP2 tubulin-binding site (TBS), and the Mus 
radixin FERM-dimerization sequence (FDS) were used to search for putative IQ, ABS, 
TBS, and FDS sites within Myo1, respectively. Modern DNA recombinant methods were 
used to PCR amplify Myo1-tail constructs and clone them into pIGF-1 (pIGF-1 figure). 
pIGF-1 was generously donated by Douglas Chalker. Restriction and polymerase 
enzymes were purchased from Promega (Madison, WI.), and primers (table 2) were 
purchased from Oligos Etc. (Wilsonville, OR.). Wild-type strain 428 Tetrahymena 
thermophila template DNA for PCR was isolated by the Stratagene DNA Isolation Kit 
(La Jolla, CA.). MYO1 coding sequence was accessed from the NCBI database (accession 
code: U87268). Amplify3.1 (Bill Engels, 2005, University of Wisconsin) and Oligotech 
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(Oligos Etc.) software was used to design primers (Table 2). The MyTH4 coding region 
was synthetically engineered and cloned into pIGF-1. 
 Primer 
Description 
Direction Sequences 
1.362 kB 
GFP-FERM 
w/ Xho I site 
Forward 5’  3’  
ATACTCGAGAAAAGTGAGTAAATACAAAGAG
GATGCATCC 
1.362 kB 
GFP-FERM 
w/ Apa I site 
Reverse 5’  3’  
TTATGGGCCCTCATTGACTTTTTTCTTATTATTG
TTGTTAC 
1.053 kB 
GFP-FERM-
T1 w/ Xho I 
site 
Forward 5’  3’  
ATACTCGAGAAAAGTGAGTAAATACAAAGAG
GATGCATCC 
1.053 kB 
GFP-FERM-
T1 w/ Apa I 
site 
Reverse 5’  3’  
TTTGGGGCCCTCATTCTTTAGAAGAAAGTGTGT
CATTTAGT 
0.438 kB 
GFP-FERM-
T2 w/ Xho1 
site  
Forward 5’  3’  
GAACTATACAAAAACCTCGAGTAAGCAAAGTT
AGCCTACATAC 
G
FP
-M
yo
1 
Ta
il 
co
ns
tru
ct
s 
0.438 kB 
GFP-FERM-
T2 region 
w/ApaI  site 
Reverse 5’  3’ 
GGTTGGTTGTTTGTTGGGCCCTCATTGACTTTT
TTCTTATTATTG 
5.656 kB 
MYO1a 
(4262 kB 
MYO1) w/ 
Acc65 I site 
Forward 5’  3’ 
GTCGACAAGACAGTTG 
 
5656 kB 
MYO1a 
(4262 kB 
MYO1) w/ Sal 
I site 
Reverse 5’  3’ 
GGTACCACAAACACTTC 
1575 kB 
MYO1b 
w/ Sac II site 
Forward 5’  3’ 
CCGCGGTTTACGTTTA D
is
ru
pt
io
n 
C
on
st
ru
ct
io
n 
1575 kB 
MYO1b 
w/ Sac I site 
Reverse 5’  3’ 
GAGCTCATTGACTTTTTTC 
 
TABLE 2. List of Primers (restriction site sequences are underlined) 
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Creation of MyTH4 and FERM Expression Constructs.   
 
Standard recombinant techniques were used to create a GFP (Green Fluorescent 
Protein)-tagged Myo1 MyTH4 (aa 1234-1376) construct by fusing 474 nucleotides of 
MYO1 tail DNA sequence to the 3’ of the GFP sequence.  An in-frame TGA stop triplet 
was fused to the 3’ of the 474 bp of Myo1 tail sequence. The 474 bp of MYO1 tail 
sequence includes all of the MyTH4 domain (429 bp) and a spacer tail domain sequence 
of 33 bp at the 5’ of MyTH4 and 12 bp of tail sequence at the 3’ of MyTH4.  Spacer 
sequences are transcribed and translated into 11 amino acids at the MyTH4 N-terminus 
and 4 amino acids at the MyTH4 C-terminus. The construct was cloned into an 
expression vector containing a metallothionein promoter, and the vector was used to 
transform Tetrahymena by biolistic bombardment.  Similarly, a GFP-tagged Myo1-
MyTH4 truncation (aa 1223-1343) construct, which eliminated a putative tubulin binding 
site, was created by fusing 360 nucleotides of MYO1 tail DNA sequence to the 3’ of the 
GFP sequence.  An in-frame TGA stop triplet was fused to the 3’ of the 360 bp of MYO1 
tail sequence.  The 360 bp of MYO1 tail sequence includes a 33 bp spacer at the 5’ of 
MyTH4 and 327 bp of the MyTH4 sequence. The truncated Myo1-MyTH4 construct is 
transcribed and translated into the first 109 of the 143 amino acids in the Myo1-MyTH4 
tail region preceded by an 11 amino acids N-terminus spacer. Similarly, a GFP-tagged 
Myo9-MyTH4 truncation (aa 1049-1226) constructed was created by fusing the genomic 
region of the MyTH4 region (bp 3145-3674) DNA to the 3’ end  of the GFP cassette. 
Each construct was separately cloned into an expression vector containing a 
methallothionein promoter, and each vector was used to transform Tetrahymena 
thermophila.  The organization of Myo1 and the predicted GFP-fusion proteins are 
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diagrammed in Fig. 2.  The expression vector (pIGF) was developed by Dr. Meng-Chao 
Yao, Institute of Molecular Biology, Taipei, Taiwan and kindly donated by Dr. Douglas 
Chalker.  
Dimensions of Myo1 FERM (Fig. 1) are based on an alignment with Mus radixin 
FERM (not shown).  Standard recombinant techniques were used to create tagged, 
truncated MYO1 tail domains by fusing a GFP (Green Fluorescence Protein) sequence to 
the 5’ end of three different regions of the MYO1 tail domain (Fig. 1B).  One truncation 
of the Myo1 tail domain (GFP-FERM) was created by fusing GFP to the last 1362 
nucleotides in the MYO1 tail (aa 1357-1809).  Therefore, in GFP-FERM, the entire region 
N-terminal to the  FERM domain was deleted.  In another truncation (GFP-FERM-T1), 
GFP was fused to the 5’ end of the first 1038 nucleotides in FERM (aa 1357-1686 ) 
followed by an inserted TGA stop triplet at the 3’ end of the truncated FERM.  For the 
third truncation (GFP-FERM-T2), GFP was fused to the 5’ end of the last 438 
nucleotides in the MYO1 tail (aa 1675-1809).  Each fused MYO1 tail sequence was 
separately cloned into an expression vector containing a metallothionein promoter, and 
the vector was used to transform Tetrahymena by biolistic bombardment.  The pIGF 
vector was developed by Dr. Meng-Chao Yao, Institute of Molecular Biology, Taipei, 
Taiwan and kindly donated by Dr. Douglas Chalker. 
Creation of Replacement Construct: 
 
Modern DNA recombinant techniques were used to create the replacement 
construct by independently PCR amplifying two different fragments of MYO1 and 
cloning them into sites that flank a disruption cassette.  MYO1A is a 5667 bp region of 
MYO1 that includes the first 4262 bp coding sequence and 1399 bp leader sequence of 
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the MYO1 coding sequence was PCR amplified using forward 5’-
GGTACCACAAACACTTC-3’ and reverse 5’-GTCGACAAGACAGTTG-3’ primers 
(Oligos etc., Wilsonville, OR), and cloned into PCR 2.1 (Invitrogen, Carlsbad, Ca).  
Similarly, MYO1B is a 1584 bp sequence of MYO1, 3’ of MYO1A, that was PCR 
amplified using forward 5’-CCGCGGTTTACGTTTA 3’ and reverse 5’-
GAGCTCATTGACTTTTTTC-3’ primers (Oligos etc), and cloned into PCR 2.1 
(Invitrogen).  MYO1A was cut with RE’s ACC65I and SalI and MYO1B was cut with 
RE’s NotI and BamHI and cloned flanking the disruption cassette in the pMrpl29B vector 
(kindly donated by Dr. Douglas Chalker).  The disruption cassette is composed of a 
cycloheximide resistance gene that is under a metallothionein promoter and a 
transcriptional terminating sequence that directly flanks the 3’ sequence of MYO1A.  The 
replacement construct was designed to replace endogenous MYO1 in Tetrahymena by 
homologous recombination and transcribe a gene that is translated to express a truncated 
Myo1 (amino acids 1-1214) followed by a 6 amino acid spacer and a translational TGA 
stop triplet, and therefore will be missing all of the MyTH4/FERM domain.  
 
Strains  
Two Tetrahymena strains will be used in this study: wild type CU427 and CU428.  
Cells will be grown in Neff’s (Orias et al., 2000) medium at 30o C. 
Antibodies 
 Anti-GFP and appropriate secondary antibodies will be purchased commercially. 
Anti-actin and anti-Myo1 are currently available in our lab from previous studies (Hosein 
et al., 2003; Hosein and Gavin, 2007).  
Mating   
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Logarithmically growing cells in Neff’s medium (Orias et al., 2000) will be 
concentrated by centrifugation, resuspended in 10 mM Tris-Cl (pH 7.4) to yield an 
optical density of 0.2 as measured at 540 nm, and they will be starved overnight at 30 
degrees C. Mating will be initiated by mixing equal numbers of cells (approximately 5-ml 
total volume) in plastic 45-ml Petri dishes. Conjugal pairs will be formed from CU427 
and CU428.  
Biolistic Bombardment of Conjugating Tetrahymena  
Biolistic bombardment was achieved with a Helios Gene Gun (Bio-Rad, 
Richmond, CA). The “bullets” were prepared with 1.0 µm gold particles according to the 
protocol described by Woods & Zito (2008). For gun shoots, a concentrated volume of 
Tetrahymena conjugal pairs (8-10 hours after mixing the mating types) were placed on 
2.4 cm GF/A sterile Whatman filter paper in 100 x15 mm plastic Petri dishes. Cells were 
fired upon three consecutive times at pressures of 120 psi, 150 psi, and 180 psi. Seven ml 
of modified Neff’s medium containing 1x antibiotic/antimycotic mix (Invitrogen, 
Carlsbad, CA) was added to the Petri dishes containing the bombarded cells, was 
incubated overnight at 30o C. Bombarded cells were subsequently diluted with modified 
Neff’s containing 100 µg/ ml paromomycin and 1x antibiotic/antimycotic mix. Two 
hundred fifty µl aliquots will be placed in Costar polypropylene cluster U-bottomed 96 
well plates (Corning, Lowell, MA) and were incubated at 30o C.  Transformants were 
evident within 3-5 days.  
Biolistic Bombardment of Conjugating Tetrahymena 
Transformation of Tetrahymena with previously described constructs was 
achieved by biolistic bombardment (Cassidy-Hanley,D. 1997; Bruns,P J. 2000 ) of 
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conjugating Tetrahymena with the Bio-Rad (Hercules, CA) hand-held Helios Gene Gun 
by the following method. Wild type 427 and 428 Tetrahymena cells were grown at 30°C 
overnight, in bottles that contained 30 ml of modified Neff’s media (Orias et al., 2000). 
Logarithmically growing cells were gently centrifuged washed three times, and 
resuspended in 30ml of 10 mM Tris-Cl (pH 7.40) to yield an optical density of 0.2 as 
measured at 540 nm, and starved overnight. The following day, approximately equal 
number of cells were mixed and allowed to mate. Conjugal pairs (8-10 hours after 
mixing) were concentrated by gentle centrifugation, placed on sterile 2.4 cm GF/A 
Whatman filter paper in 100 x 15 mm plastic Petri dishes, and were fired upon three 
consecutive times with fresh “bullets” at pressures of 120 psi, 150 psi, and 180 psi.  
Preparation of “Bullets” and Use of Gene Gun. 
The “bullets” consist of 1.0 micron DNA coated gold particles that were prepared 
by the following procedure adapted from the Woods and Zito (2008) protocol and the 
Bio-Rad handbook protocol.  
1. Preparation of DNA 
Fresh PolyVinylPyrolidone (PVP) ethanol suspension solution was prepared by 
adding 175 µL of 20mg/ml PVP solution in a sterile screw cap container, and the solution 
was diluted with fresh ethanol to make a final volume of 3.5ml (i.e. final concentration is 
0.01mg/ml PVP). 50 µL of 200 proof ethanol was added to 50 µL of 0.10 spermidine in a 
microfuge tube containing 50 mg of 1.0 micron Gold (Au) particles and the mixture was 
sonicated and vortexed for 2-3 secs. 100 µg (100 µL) DNA, which was prepared by the 
Qiagen (Valencia, CA) HiSpeed Maxi Plasmid Prep Kit, was added to the gold & 
spermidine solution, and the mixture was gently sonicated. Drop-wise, 100µl of Calcium 
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Chloride (2.5M) was added to the mixture and sonicated for 2-3 minutes. The mixture 
was allowed to precipitate at room temperature for 10 min, and then briefly sonicated. 
The mixture was pulse-centrifuged for 15seconds, and the supernatant was removed and 
discarded. The mixture was resuspended in the remaining supernatant, and washed 3-
times with 1ml fresh EtOH. After the final wash, repeated 200ul of PVP solution was 
used to transfer solution into freshly made PVP solution.  
2. Coating the Plastic (From Bio-Rad protocol):  
A ~ 30 inch tube was cut and dried in the tube prep station with Nitrogen at 0.35-
0.4 Liters Per Minute(s) (LPM) for at least 15 minutes. The DNA coated gold mixture 
was inverted several times. Most of the mix was drawn and quickly transferred to the 
dried tube. The micro-carriers were allowed to settle for 3-5minutes. The solution was 
removed at a rate of 0.5-1.0”/ sec (the tube is emptied in within 30-45 secs). The tube was 
rotated 180 degrees and the gold was allowed to coat the inside of the tubing for 3-4 secs. 
The tubing prep station was turned on (I) to start rotating and the Gold to smeared the 
tubing for 20-30 second. The nitrogen valve was later opened to allow Nitrogen out at 
0.35-.4LPM for 3-5 minutes. Finally, the rotator was turned off, and the nitrogen valve 
was closed.  
3. Cutting the Tubing:  
A vial with desiccant pellet inside was placed in the base of the tubing cutter (hole 
under the cutter). The tubing was inserted until it made contact with rear. The cutter was 
pressed down to cute DNA-coated, gold-smeared tube. Unused bullets were stored at 4°C 
in a tightly capped vial labeled, and wrapped in parafilm.  
 84 
4. Using the Gun:  
An empty cartridge holder was inserted into the Helios Gene Gun, and the gun 
was pressurized to fire at 200 ATM. Loaded bullets were loaded into the cartridge holder 
and were fired at unsuspecting Tetrahymena. Bombarded cells were incubated overnight 
at 30C and the diluted with modified Neff’s containing 120 µg/ml paromomycin and 1x 
antibiotic/antimycotic mix. Two hundred fifty µL aliquots were placed in Corning 
(Lowell, MA) 96 well plates and incubated at 30°C. Transformants were evident within 
3-5 days. 
Verification of Replacement Construct: 
 
 Genomic DNA was extracted from wild type 428 and MYO1 truncated 
replacement strains of Tetrahymena thermophila using the Stratagene DNA Isolation Kit 
(La Jolla, CA.) and were separately used as template for PCR reactions.  Two primers 
(Eurofins, Huntsville, Al), forward 5’-AGCTATCTGAATTAGGAGAGTAGAAGC-3’ 
and reverse 5’-CTACTGGTTGTTGGCAGTATGCTG-3’ were used to verify the 
replacement of endogenous MYO1.  The PCR product for wild type strains expressing 
endogenous MYO1 was expected to be 1181 nucleotide bases. The PCR product for the 
replacement construct was expected to be 2489 nucleotide bases. The running condition 
for the PCR reaction was (94°C, 30 seconds; 62°C, 30 seconds; 72°C, 2:30 minutes; 30 
cycles).  
Expression of GFP-MyTH4 
Transformed cells were grown for 8-12 hours at 30oC prior to induction of GFP-
MyTH4 expression by addition of 1.0 µg/ml CdCl2.  Cells were analyzed 6-12 hours after 
induction of GFP-MyTH4 expression. 
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Growth Curves  
Spectrophotometer analysis at 540 nm was used to measure the growth rate of 
wild type and transformed Tetrahymena. Cells were grown in Neff’s media supplemented 
with 0.1-0.5 µg/ml cadmium chloride at 30°C in 500 ml of culture medium contained in 
2.8 liter Fernbach flasks. 
Lysates  
 GFP-MyTH4 transformants were grown for two nights in 30 ml bottles of Neff’s 
media at 30°C, and were treated to three hours of 1.0 µg/ml of CdCl2 the next morning. 
However, GFP-FERM transformants cells were grown overnight in 30 ml bottles of 
Neff’s media at 30°C. transformant cells were subsequently grown overnight in 0.5 µg/ml 
of CdCl2 and incubated another night at 30°C. The cells were lysed with SDS according 
to the Hosein et al., 2003 protocol. To minimize protein degradation, Sigma-Aldrich 
protease inhibitors (St. Louis, MO) were added to the lysis buffer. Cells were 
concentrated and lysed by mixing with a solution consisting of 50 mM Tris-HCl (pH 8.0), 
150 mM NaCl, 20 mM EDTA, 1% Na-deoxycholate, 1% Trition X-100 (Williams, 
2000), and protease inhibitors (Turkewitz et al., 2000) for co-immunopreciptitation and 
low-speed sedimentation assays.  
Immunoprecipitations 
Lysates were treated with 1ml rabbit anti-actin serum (clone 7167) and incubated 
overnight at 4°C. One-milliliter of Protein A-agarose beads (Bio-Rad) was prepared by 
washing with Tris-Buffered Saline at pH 8.0 (TBS) until the OD280 was zero and 
resuspended in TBS for a total volume of ~1ml. Lysate and antiserum mixture was 
incubated with Protein A-agaorse beads for 2 hours in ice water with shaking. The 
 86 
immunoprecipitate/Protein A-agarose beads mixture was washed again with TBS, until 
the OD280 was zero. Immuno-complexes were eluted with glycine at pH 3.0 from the 
beads and the eluate was immediately treated with 1.0M Tris-HCl (pH 8.0) to bring up 
the pH to 8.0. The same procedure as described for immune serum was completed with 
rabbit non-immune serum treatment with lysate for control experiments. 
Affinity Purification with antiGFP-Agarose 
Affinity resin was prepared by applying 400 µL of 100 µg/ml GFP polyclonal 
antibody (Invitrogen) to an NHS-Activated agarose spin column (33 mg capacity) 
(Pierce) and incubating at 4°C overnight.  Unbound GFP-antibody was removed by 
centrifugation and the column was washed twice with phosphate buffered saline (PBS): 
13.7 mM NaCl, 0.27  mM KCl, 10 mM Na2HPO4, 0.2 mM KH2PO4, pH 7.4.   Agarose 
reactivity was quenched with 1.0 M ethanolamine (pH 7.4), and the quenched spin 
column was washed with PBS until OD at 280 was zero.  Non-denatured, twice clarified, 
whole cell lysate from cells overexpressing GFP-MyTH4 was prepared as described for 
immunopreciptation and added to the spin column along with 10 mM Mg-ATP.  The 
column was incubated overnight at 4°C overnight and subsequently washed with PBS 
until OD at 280 was zero.  The column was eluted with 400 µL of 0.5 ml glycine (pH 
3.0) and neutralized with 25 µL of 1.0 mM Tris (pH 8.0). 
Electrophoresis 
Lysates were separated on NuPage 4-12% Bis-Tris gels and stained with Novex 
colloidal blue from Invitrogen (Carlsbad, California) for gel analysis. Gels were 
electrophoretically transferred to PVDF membranes (Bio Rad) using standard methanol-
based transfer protocols.  
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SDS-PAGE.   
Transformed cells were grown overnight in Neff’s medium at 30o C.  
Subsequently, CdCl2 at a final concentration of 0.5 µg/ml was added to the culture, which 
was again incubated overnight at 30o C.  Protocols for SDS-solubilized total cell lysate 
were previously described (Hosein et al., 2003).  Polypeptides were separated on NuPage 
(Invitrogen) 4-12% Bis-Tris gels and stained with Coomassie Blue.  Gel loadings were 
equal for all lysates. 
Immunoblotting 
Proteins were electrophoretically transferred to a PVDF membrane (Bio Rad) 
using standard methanol-based transfer protocols.  Membranes were probed with 
appropriate antibodies in accordance with standard methods for immunoblotting.  
Immunoblots were developed with ECL Western Blotting Substrate (Pierce) and Biomax 
XAR film (Kodak).    
Actin Filaments 
Muscle F-actin (Cytoskeleton, Inc) was stabilized by treatment with 1.0 µM 
Alexa-Fluor 568-phalloidin (Invitrogen) in binding buffer (5.0mM Tris-HCl (pH 8.0), 0.2 
mM CaCl2, 2.0 mM MgCl2, 5.0% glycerol). 
Preparation of Microtubules 
Tubulin and all other reagents for MT polymerization were purchased from 
Cytoskseleton, Inc (Denver, CO). Microtubules were polymerized from rhodamine 
labeled tubulin mixed with unlabeled tubulin (1:1) according to the manufacturer’s 
protocol which is as follows:  All reagents including labeled and unlabelled tubulin was 
thawed out. Sixty microliter of G-PEM solution was prepared by thorough mixing of 59.4 
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µl general tubulin buffer, and 0.6 µl 100mM of GTP. Four microliters of G-PEM solution 
and 1 µl of microtubule cushion buffer were added to rhodamine tubulin. Ten aliquots of 
unlabelled tubulin were prepared by adding 45 µl of G-PEM solution and 4.5 µl of 
Microtubule cushion buffer to unlabelled tubulin.  Five micro liters of unlabeled tubulin 
solution was added to 5ul rhodamine-labeled tubulin to make a 1:1 ratio. The mixture 
was incubated at 35 °C for 25 minutes. Five-hundred micro-liters of General tubulin 
buffer was incubated at 35 °C for 15 minutes, followed by the addition 5 µl of taxol to 
tubulin buffer and the solution was stored at room-temperature. One hundred microliters 
of taxol-tubulin buffer was added to the tubulin after the 25-minute incubation period 
ended. The polymerized tubulin was observed by adding 1 µl of tubulin mixture in 20 µl 
of tubulin buffer-1x antifade mixture under confocal microscope.  
Preparation of Whole Cell Extracts for Cosedimentation Assays 
To prepare whole cell extracts, cells were washed free of culture medium and 
resuspended in extraction lysis buffer: 10 mM Tris pH 7.4, 20 mM KCl, 0.1 mM EGTA, 
5 mM MgCl2, 2 mM DTT, and 200 µl protease inhibitor/ml lysis buffer.  The 
concentrated cell suspension was frozen at -20 °C for 10 minutes and subsequently 
thawed at room temperature, then put through a vigorous vortex and drawn up into a 
Pasteur pipette several times to lyse the cells.  The lysate was clarified by centrifugation 
at 16,000 x g for 15 minutes.  The supernatant was centrifuged a second time at 16,000 x 
g for 15 minutes.  Supernatant from the second centrifugation was used in 
cosedimentation assays. 
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Cosedimentation Assays With GFP-MyTH4 IP 
Phalloidin-stabilized F-actin (15 µM) in binding buffer containing 10  mM ATP 
was incubated with 160 µl of antiactin immunoprecipitation (IP) pellet for 15 minutes at 
4°C followed by centrifugation at 16,000 x g for 15 minutes.  The pellet was resuspended 
in 100 µl of actin-binding buffer and subsequently prepared for confocal microscopy.  
For microtubule cosedimentation assays 160 µl of antiactin GFP-MyTH4 IP were 
incubated with 3.5 µM taxol-stabilized microtubules in polymerization buffer for 15 
minutes at 30°C followed by centrifugation at 16,000 x g for 15 minutes.  The pellet was 
resuspended in 100 µl of binding buffer and used for confocal microscopy.  For 
cosedimentation assays involving both F-actin and microtubules, 160 µl of antiactin 
GFP-MyTH4 IP were incubated with 3.5 µM taxol-stabilized microtubules in 
polymerization buffer for 15 minutes, and then 15 µM unlabeled F-actin in actin-binding 
buffer containing 10 mM ATP were added for another 15 minutes incubation.   
Cosedimentation Assays With Whole Cell Extracts  
For actin filament cosedimentation assays, stabilized F-actin (15 µM) was 
incubated with 160 µl of the cell lysate (with added 10 mM Mg-ATP) for 15 minutes at 
40 C followed by centrifugation at 16,000 x g for 15 minutes.  The pellet was resuspended 
in 100 µl of actin-binding buffer and subsequently prepared for confocal microscopy.  
For microtubule cosedimentation assays, 160 µl of whole cell lysate were incubated with 
3.5 µM taxol-stabilized microtubules in polymerization buffer for 15 minutes at 30°C 
followed by centrifugation at 16,000 x g for 15 minutes.  The pellet was resuspended in 
100 µl of binding buffer and used for confocal microscopy.  F-actin and microtubules 
were viewed from wet mounts sealed with nail polish. 
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Cosedimentation Assays with AntiGFP Pulldown Fraction 
For actin filament cosedimentation assays, stabilized F-actin (15 µM) was 
incubated with 160 µl of antiGFP pulldown (with added 10 mM Mg-ATP) for 15 minutes 
at 4oC followed by centrifugation at 16,000 x g for 15 minutes.  The pellet was 
resuspended in 100 µl of binding buffer and used for confocal microscopy For 
microtubule cosedimentation assays, 160 µl of antiGFP pulldown fraction were incubated 
with 3.5 µM taxol-stabilized microtubules in polymerization buffer for 15 minutes at 300 
C followed by centrifugation at 16,000 x g for 15 minutes.  The pellet was resuspended in 
100 µl of binding buffer and used for confocal microscopy. 
Confocal Microscopy of Living Cells 
Living cells were embedded in a thin layer of 1.7 % low melting agarose on slide. 
Actin filaments and microtubules were viewed from wet mounts sealed with nail enamel. 
For observation of nuclei, DAPI (4’, 6-diamidino-2-phenylindole, dihydrochloride) was 
used at a concentration of 10 µg/ml. Confocal microscopy was performed with a C-1 
confocal system (Nikon, Inc., Melville, NY). A 60x 1.4 N.A. Nikon Apochromat oil 
immersion lens was used to capture images. 
Isolation of Nuclei 
To prepare a cell fraction enriched for nuclei, cells were washed free of culture 
medium and resuspended in extraction lysis buffer: 10 mM Tris pH 7.4, 20 mM KCl, 0.1 
mM EGTA, 5 mM MgCl2, 2 mM DTT, and 200 µl protease inhibitor (Sigma)/ ml lysis 
buffer.  The concentrated cell suspension was frozen at -20°C degrees for 10 minutes and 
subsequently thawed at room temperature, then gently drawn up into a Pasteur pipette 
several times to lyse the cells without rupturing nuclear membranes.  The extract was 
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centrifuged at 800 x g for 10 minutes.  The supernatant was discarded; the pellet was 
resuspended in extraction buffer and centrifuged a second time at 800 x g for 10 minutes.  
The supernatant from the second centrifugation was discarded; the pellet, which 
contained intact nuclei, was resuspended in 100 µl extraction buffer and used for 
microscopy analysis. 
Nocodazole 
Cells overexpressing GFP-MyTH4 were given a 30 minute treatment with 30 mM 
nocodazole prior to fixation for immunofluorescence microscopy.  Control cells received 
a 30-minute treatment with DMSO prior to processing for immunofluorescence 
microscopy. 
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Chapter 9. Closing Remarks  
Replacement Construct for MYO1 
A Replacement construct for MYO1 was used to transform Tetrahymena with a 
truncated version of Myo1 that lacked MyTH4/FERM region of Myo1. PCR confirmed 
replacement of endogenous Myo1 gene, and immunoblot analysis showed stable 
expression of truncated Myo1 (not shown). However, complete phenotypic assortment 
for this gene was not achieved, as observed in PCR analysis and western blots, implying 
that Myo1 truncated for MyTH4/FERM is lethal to Tetrahymena.  
 93 
Chapter 10 Bibliography 
 
 
Adams, R. J., and Pollard T.D. (1986). Propulsion of organelles isolated from 
Acanthamoeba along actin filaments by myosin-I. Nature, 322(6081), 754-756. 
Adams, R. J., and Pollard T.D. (1989). Binding of myosin I to membrane lipids. Nature, 
340(6234), 565-568.  
Allen RD. 1967. Fine structure, reconstitution, and possible functions of components of 
the  cortex of Tetrahymena pyrifoirmis.  J Protozool 14, 553-565. 
Allen, R., & Wolf, R. (1979). Membrane recycling at the cytoproct of Tetrahymena. 
Journal of Cell Science, 35(1), 217-227. 
Awan, A., Hamasaki, T., and Satir, P. (2004). Cloning and characterization of Kin5, a 
novel Tetrahymena ciliary kinesin II. Cell Motility and the Cytoskeleton, 58, 1-9. 
Banga, I. (1942). The phosphatase activity of myosin. Stud. Inst. Med. Chem. Univ.
 Szeged. (I), 27–36. 
Banga, I., and A. Szent-Györgyi. (1942). Preparation and properties of myosin A and B. 
Stud. Inst. Med. Chem. Univ. Szeged. (I), 5-15. 
Barsoum, I.B., King-Smith, C., Myosin II and Rho kinase activity are required for 
melamosome aggregation in fish retinal pigment epithelial cells. (2007). Cell 
Motility and the Cytoskeleton, 64, 868-879 
Basciano, P. A. & King-Smith, C. (2002) Pigment Cell Res. 15 ,  184–191. 
Belyantseva, I.A., Boger, E.T., Naz, S., Frolenkov G.I., Sellers J.R., Ahmed Z.M., 
Griffith, A.J., and Friedman T.B. (2003). Myosin XVa localizes to the tips of 
inner ear sensory cell stereocilia and is essential for staircase formation of the hair 
bundle. Proc Natl Acad Sci USA., 100(24), 13958-13963.  
Belyantseva, I.A., Boger, E.T., and Friedman T.B. (2005). Myosin-XVa is required for 
tip localization of whirlin and differential elongation of hair-cell stereocilia. 
Nature Cell Biology,  7, 148-156.  
Berg JS, Derfler BH, Pennis CM, Corey DP, Cheney RE. 2000. Myosin-X, a novel 
myosin with pleckstrin homology domains, associates with regions of dynamic 
actin. J Cell Sci 113, 3439-3451. 
 94 
Berg, J., Powell, B., & Cheney, R. (2001). A millennial myosin census. Molecular 
Biology of the Cell, 12(4), 780-794.  
Blackburn, E. H. (1978). A tandemly repeated sequence at the termini of the 
extrachromosomal ribosomal RNA genes in tetrahymena. Journal of Molecular 
Biology, 120(1), 33-53.  
Bleyman, L. K. (1992). Mapping the mating type locus of Tetrahymena thermophila: 
Meiotic linkage of mat to the ribosomal RNA gene. Devel Genetics, 13(1), 34-40. 
Bohil, A. B., Robertson, B. W., & Cheney, R. E. (2006). Myosin-X is a molecular motor 
that functions in filopodia formation. PNAS USA, 103(33), 12411-12416.  
Breshears LM, Wessels D, Soll DR, Titus MA. 2010.  An unconventional myosin 
required for cell polarization and chemotaxis. PNAS USA 107, 6918-6923. 
Bretscher A, Edwards K, Fehon RG.  2002  ERM proteins and merlin: integrators at the 
cell cortex.  Nat Rev Mol Cell Biol., 3, 586-599. 
Bretscher, A., Reczek, D., & Berryman, M. (1997). Ezrin: A protein requiring 
conformational activation to link microfilaments to the plasma membrane in the 
assembly of cell surface structures. Journal of Cell Science, 110(24), 3011-3018. 
Bruns, P.J. (1986). Genetic organization of Tetrahymena. In: Gall, L. G. (ed.), 
TheMolecular Biology of Ciliated Protozoa. Academic Press, Orlando. p. 27-44. 
Bruns, P. J., and Cassidy-Hanley, D. (2000). Biolistic transformation of macro- and 
micronuclei.  In: Asai, D.J., and Forney, J.D. (ed), Tetrahymena thermophila. 
Methods in Cell Biology, V(62). Academic Press, San Diego. p. 501-512. 
Brzeska, H., Lynch, T., & Korn, E. (1988). Localization of the actin-binding sites of 
acanthamoeba myosin IB and effect of limited proteolysis on its actin-activated 
Mg2+-ATPase activity. Journal of Biological Chemistry, 263(1), 427-435. 
Cassidy-Hanley, D., Bowen, J., Lee, J. H., Cole, E., VerPlank, L. A., Gaertig, J.,   
Gorovsky, M.A. and Bruns, P.J. (1997). Germline and somatic transformation of 
mating tetrahymena thermophila by particle bombardment. Genetics, 146,135-47. 
Cao, T.T., Chang, W., Masters, S.E., and Mooseker M.S., (2004). Myosin-Va Binds to 
and Mechanochemically Couples Microtubules to Actin Filaments. MBC., 15(1), 
151-161. 
 95 
Chambers DN, Bretscher A. 2005. Ezrin mutants affecting dimerization and activation. 
Biochemistry 44, 3926-3932.  
Cech, T.R.  1986 . A model for the RNA-catalyzed replication of RNA. Proc Natl Acad 
Sci USA., 83(12), 4360-4363. 
Chasey, D., (1969). Observations on the Central Pair of Microtubules from the Cilia of 
Tetrahymena Pyriformis. Journal of Cell Science, (5), 453-458. 
Chaparro-Olaya J, Margos G, Coles DJ, Dluzewski AR, Mitchell GH, Wasserman MM, 
Pinder JC.  2005.  Plasmodium falciparum myosins: transcription and translation 
during asexual parasite development. Cell Motil Cytoskel 60, 200-213. 
Chen, Z.Y., Hasson, T., Kelley, P.M., Schwender, B.J., Schwartz, M.F., Ramakrishnan, 
M., Kimberling, W.J., Mooseker M.S., and Corey, D.P. (1996). Molecular 
cloning and domain structure of human myosin-VIIa, the gene product defective 
in usher syndrome 1B. Genomics, 36(3), 440-448. 
Cheney, R. E. and Mooseker M.S. (1992). Unconventional myosins. Current Opinion in 
Cell Biology, 4(1), 27-35.  
Chishti AH, Kim AC, Marfatia SM,  Lutchman M, Hanspal M, Jindal H, Liu SC, Low 
PS,  Rouleau GA, Mohandas N, and others. 1998.  The FERM domain: a unique 
module involved in the linkage of cytoplasmic proteins to the membrane.  Trends 
Biochem  Sci,  23, 281-282.  
Chuang, C., Carpenter, A., Fuchsova, B., Johnson, T., deLanerolle, P., and Belmont, A. 
(2006). Long-range directional movement of an interphase chromosome site. 
Current Biology, 16(8), 825-831.  
Cleffmann G.  1980. Chromatin elimination and the genetic organisation of the 
macronucleus in Tetrahymena thermophila. Chromosoma. 78, 313-325. 
Conboy,  J., Kan Y.W., Shohet, S.B., Mohandas N. (1986). Molecular cloning of protein 
4.1, a major structural element of the human erythrocyte membrane skeleton. 
Proc Natl Acad Sci USA., 
 Coluccio LM. 2008. Myosins: A Superfamily of Molecular Motors (Proteins and Cell 
Regulation).  New York: Springer, 469pp. 
 96 
Correas I., Padilla R., and Avila J., (1990). The tubulin-binding sequence of brain 
microtubule-associated proteins, tau and MAP-2, is also involved in actin binding. 
Biochem J. 269(1), 61–64. 
Coue, M., Brenner, S.L., Spector, I., Korn, E.D. (1987). Inhibition of actin 
polymerization by latrunculin A. FEBS Letters 213(2), 316-318.  
Diakowski, W. (2006). Protein 4.1, a component of the erythrocyte membrane skeleton 
and its related homologue proteins forming the protein 4.1/FERM superfamily. 
Folia Histochemica Et Cytobiologica, 44(4), 231-248.  
Doberstein, S., and Pollard, T. (1992). Localization and specificity of the phospholipid 
and actin binding sites on the tail of acanthamoeba myosin IC. The Journal of 
Cell Biology, 117(6), 1241-1249.  
Doll T., Meichsner M., Riederer B.M., Honegger P., and Matus A. (1993). An isoform of 
microtubule-associated protein 2 (MAP2) containing four repeats of the tubulin-
binding motif. Journal of Cell Science, 106( 2), 633-639. 
 Durbach A., Collins K., Matsudaira, R., Louvard, D., Coudrier, E. (1996). Brush border 
myosin-I truncated in the motor domain impairs the distribution and the function 
of endocytic compartments in an hepatoma cell line. Proc Natl Acad Sci USA 
93(14) 7053-7058  
Eisen, J.A., Coyne, R.S., Wu, M., Wu, D., Thiagarajan, M., Wortman, J.R., Badger, J.H., 
Ren, Q., Amedeo, P., Jones, K.M., Tallon, L.J., Delcher, A.L., Salzberg, S.L., 
Silva, J.C., Haas, B.J., Majoros, W.H., Farzad, M., Carlton, J.M., Smith, R.K. Jr., 
Garg, J., Pearlman, R.E., Karrer, K.M., Sun, L., Manning, G., Elde, N.C., 
Turkewitz, A.P., Asai, D.J., Wilkes, D.E., Wang, Y., Cai, H., Collins, K., Stewart, 
B.A., Lee, S.R., Wilamowska, K., Weinberg, Z., Ruzzo, W.L., Wloga, D., 
Gaertig, J., Frankel, J., Tsao, C.C., Gorovsky, M.A., Keeling, P.J., Waller, R.F., 
Patron, N.J., Cherry, J.M., Stover, N.A., Krieger, C.J., del Toro, C., Ryder, H.F., 
Williamson, S.C., Barbeau, R.A., Hamilton, E.P., Orias, E. (2006). Macronuclear 
genome sequence of the ciliate Tetrahymena thermophila, a model eukaryote. 
PLoS biology. 4(9)  
 97 
Elde, N. C., Morgan, G., Winey, M., Sperling, L. and Turkewitz, A. P. (2005). 
Elucidation of clathrin-mediated endocytosis in tetrahymena reveals an 
evolutionarily convergent recruitment of dynamin. PLoS Genet. 1(52), 524-522.  
Engelhardt, V. A., and Lyubimowa, M. N. (1939). Myosin and adenosinetriphosphatase. 
Nature, 144, 668-669.  
Etournay, R., Zwaenepoel, I., Perfettini, I., Legrain, P., Petit, C., & El-Amraoui, A. 
(2007). Shroom2, a myosin-VIIa- and actin-binding protein, directly interacts 
with ZO-1 at tight junctions. Journal of Cell Science, 120(16), 2838-2850.  
Flickinger, C. J. (1965). The fine structure of the nuclei of Tetrahymena pyriformis 
throughout the cell cycle. The Journal of Cell Biology, 27(3), 519-529.  
Finnerty CM, Chambers D, Ingraffea J, Faber HR, Karplus PA, Bretscher A.  2004. The 
EBP50-moesin interaction involves a binding site regulated by direct masking on 
the FERM domain.  J Cell Sci. 117, 1547-1552. 
Foth, B., Goedecke, M., and Soldati, D. (2006). From the cover: New insights into 
myosin evolution and classification. Proc Natl Acad Sci., 103(10), 3681-3686.  
Fujiu K, Numata, O.  2000  Reorganization of microtubules in the amitotically dividing 
macronucleus of Tetrahymena. Cell Motil. Cytoskeleton, 46, 17-27. 
Fukui, Y. (1989). Myosin I is located at the leading edges of locomoting Dictyostelium 
amoebae. Nature, 341(6240), 328-331.  
Gaertig, J., Gu, L., Hai, B., and Gorovsky M.A. (1994). High frequency vector-mediated 
transformation and gene replacement in tetrahymena. Nucleic Acids Research, 22, 
5391-5398.  
Garces. J. A. & Gavin, R. H. 1996. Identification of a myosin heavy chain gene 
(TETMYO-1 ) in Tetrahymena. Mol. Bio. Cell 7(37), 869-881. 
Garcés, J. and Gavin R.H., (1998). A PCR screen identifies a novel, unconventional 
myosin heavy chain gene (MYO1) in tetrahymena thermophila. The Journal of 
Eukaryotic Microbiology, 45(3), 252-259.  
Gavin, R. H. (1980). The oral apparatus of tetrahymena. V. oral apparatus polypeptides 
and their distribution. Journal of Cell Science, 44(1), 317-333.  
Gavin, R. H. (1997). Microtubule-Microfilament Synergy in the Cytoskeleton. In: Int Rev 
Cytol, (173). New York, Academic Press. p. 207-242. 
 98 
Gavin R.H. (1999) Synergy of cytoskeleton components. BioScience, 49(8), 641-655. 
Gavin, R. H. (2001). Myosins in protists. In: Int Rev Cytol, (206). New York, Academic 
Press. p. 97-134. 
Gillespie, P., and Cyr, J. (2002). Calmodulin binding to recombinant myosin-1c and 
myosin-1c IQ peptides. BMC Biochemistry 3(1), 31-48.  
Gotesman M, Hosein RE, Gavin RH. 2010.  A FERM domain in a class XIV myosin 
interacts with actin and tubulin and localizes to the cytoskeleton, phagosomes, 
and nucleus in Tetrahymena thermophila. Cytoskeleton 67:90-101. 
Greider, C. W. (1985). Identification of a specific telomere terminal transferase activity 
in Tetrahymena extracts. Cell, 43(2 Pt 1), 405-413.  
Griffith L.M. and Pollard T.D. (1978). Evidence for actin filament-microtubule 
interaction mediated by microtubule-associated proteins. JCB, (78), 958-965. 
Guerra, C., Wada, Y., Leick, V., Bell, A., and Satir, P. (2003). Cloning, localization, and 
axonemal function of tetrahymena centrin. Molecular Biology of the Cell, 14(1), 
251-261. 
Halliburton W.D., (1887). On muscle-plasma. J Physiol (8), 11-202.  
Hamada K, Shimizu T, Matsui T, Tsukita S, Hakoshima T.  2000. Structural basis of the 
membrane-targeting and unmasking mechanisms of the radixin FERM domain. 
EMBO J. 19: 4449-4462. 
Hamada K, Shimizu T, Yonemura S, Tsukita S, Tsukita S, Hakoshima T. 2003.  
Structural basis of adhesion-molecule recognition by ERM proteins revealed by 
the crystal structure of the radixin-ICAM-2 complex.  EMBO J, 22, 502-514. 
Hammonda JW, Caia D, Verhey KJ.  2008.  Tubulin modifications and their cellular 
functions.  Curr Opin Cell Biol 20:71-76. 
Hasson, T., Gillespie, P.G., Garcia, D.J.A., MacDonald, R.B., Zhao Y.D., Yee D.A.G., 
Mooseker M.S., Corey D.P. (1997). Unconventional myosins in inner-ear sensory 
epithelia. The Journal of Cell Biology, 137(6), 1287-1307.  
Hirono, M., Nakamura, M., Tsunemoto, M., Yasuda, T., Ohba, H., Numata, O. and 
Watanabe, Y. (1987). Tetrahymena actin: Localization and possible biological 
roles of actin in Tetrahymena cells. J. Biochem. 102, 537-545.  
 99 
Hoffmann, E.K., Rasmussen, L., and Zeuthen, E. (1974). Cytochalasin B: Aspects of 
Phagocytosis in Nutrient Uptake in Tetrahymena. J Cell Sci. 15, 403-406. 
Hoey JG, Gavin RH. 1992. Localization of actin in the Tetrahymena basal body cage 
complex.   J Cell Sci ,103, 629-641. 
Horowitz S, Gorovsky MA. 1985.  An unusual genetic code in nunclear genes of 
Tetrahymena.  Proc Natl Acad Sci, 82, 2452-2455. 
Hosein, R. E., Williams, S.A., and Gavin, R.H. (2005). Directed motility of phagosomes 
in Tetrahymena thermophila requires actin and Myo1p, a novel unconventional 
myosin. Cell Motility and the Cytoskeleton, 61(1), 49-60.  
Hosein, R. E., and Gavin R.H. (2007). Myo1 localizes to phagosomes, some of which 
traffic to the nucleus in a Myo1-dependent manner in Tetrahymena thermophila. 
Cell Motility and the Cytoskeleton, 64(12), 926-937.  
Huang, S., Jagadeeswaran, R., Liu, E. S., and Benz, E. J., Jr. (2004). Protein 4.1R, a 
microtubule-associated protein involved in microtubule aster assembly in 
mammalian mitotic extract. Journal of Biological Chemistry, 279(33), 34595-
34602.  
Hulo N., Bairoch A., Bulliard V., Cerutti L., Cuche B., De Castro E., Lachaize C., 
Langendijk-Genevaux P.S., and Sigrist C.J.A. (2008). The 20 years of PROSITE. 
Nucleic Acids Res. PS,=D245-D249. 
Huxley, A. F. (1954). Structural changes in muscle during contraction interference 
microscopy of living muscle fibres. Nature, 173(4412), 971-973.  
Jacobs, M. E., DeSouza, L. V., Samaranayake, H., Pearlman, R. E., Siu, K. W. M., and 
Klobutcher, L. A. (2006). The Tetrahymena thermophila phagosome proteome. 
Eukaryotic Cell, 5(12), 1990-2000.  
Katijama, Y., and Thompson, G.A. Jr., (1977). Differentiation of Food Vacuolar 
Membranes During Endocytosis in Tetrahymena. Journal of Cell Biology, 75, 
436-445.  
Kiehart, D.P., Franke J.D., Chee M.K., Montague R.A., Chen T.L., Roote J., and 
Ashburner M. (2004). Drosophila crinkled, Mutations of Which Disrupt 
Morphogenesis and Cause Lethality, Encodes Fly Myosin VIIA. Genetics, 168, 
1337-1352. 
 100 
Kitano K, Yusa F, Hakoshim T. 2006. Structure of dimerized radixin FERM domain 
suggests a novel masking motif in C-terminal residues 295–304. Acta Crystallogr 
Sect F Struct Biol Cryst Commun., 62, 340–345. 
Langford G.M. (1995). Actin- and microtubule-dependent organelle motors: 
interrelationships between the two motility systems. Curr Opin Cell Biol. (1), 82-
88. 
Lee HS, Bellin RM., Walke DL, Patel B, Powers P, Liu H, Garcia-Alvarez B, de Pereda 
JM, Liddington RC, Volkmann N, Hanein D, Critchley DR, Robson, RM.  2004.  
Characterization of an actin-binding site within the talin FERM domain.  J. Mol 
Biol 343, 771-784. 
Lee, H. Bellin, R.B., Walker, D.L., Patel B., Powers, P., Liu,  Garcia-Alverz, B., Pereda, 
J.M.D., Liddington, R.C., Volkmann, N., Hamein, D., Critchley, D.R., and 
Robson, M. (2004). Characterization of an actin-binding site within the talin 
FERM domain. Journal of Molecular Biology, 343(3), 771-784.  
Lee, W., Ostap, E. M., Zot, H. G., and Pollard, T. D. (1999). Organization and ligand 
binding properties of the tail of acanthamoeba myosin-IA. Identification of an 
actin-binding site in the basic (Tail Homology-1) domain. Journal of Biological 
Chemistry, 274(49), 35159-35171.  
Lengsfeld A.M., Löw, I., Wieland, T., Dancker, P., and Hasselbach W. (1974). 
Interaction of Phalloidin with Actin. Proc Natl Acad Sci 71(7), 2803–2807. 
Lewis S.A., Wang D.H., and Cowan N.J. (1988). Microtubule-associated protein MAP2 
shares a microtubule binding motif with tau protein. Science 242(4880), 936-939 
Li Q, Nance MR, Kulikauskas R, Nyberg K, Fehon R, Karplus PA, Bretscher A, Tesmer 
JJ.  2006. Self-masking in an intact ERM-merlin protein: an active role for the 
central alpha-helical domain. J Mol Biol., 365, 1446-1459. 
Liu, R., Woolner, S., Johndrow, J. E., Metzger, D., Flores, A. and Parkhurst, S. M. 
(2008). Sisyphus, the Drosophilamyosin XV homolog, traffics within filopodia 
transporting key sensory and adhesion cargos. Development, 135, 53-63. 
Lu, Q., and Henderson E. (2000). Two tetrahymena G-DNA-binding proteins, TGP1 and 
TGP3, share novel motifs and may play a role in micronuclear division. Nucleic 
Acids Research, 28(15), 2993-3001.  
 101 
Lymn, R.W., and Taylor E.W. (1971). Mechanism of adenosine triphosphate hydrolysis 
by actomyosin. Biochemistry, 10(25), 4617-4624.  
Mattagajasingh, S.N., Huang, S.C.,  Hartenstein, J.S., and Benz E.J. (2000). 
Characterization of the interaction between protein 4.1 R and ZO-2. A possible 
link between the tight junction and the actin cytoskeleton. The Journal of Biological 
Chemistry, 275(39), 30573-30585.  
McNeil, E. L., Tacelosky, D., Basciano, P., Biallas, B., Williams, R., Damiani, P., 
Deacon, S., Fox, C., Stewart, B., Petruzzi, N., Osborn, C., Klinger, K., Sellers, J. 
R., and Smith, C. K. (2004) Cell Motil. Cytoskeleton, 58, 71-82 
Muranen T., Grönholm M., Lampin A., Lallemand D., Zhao F., Giovannini M., and 
Carpén O. (2007). The tumor suppressor merlin interacts with microtubules and 
modulates Schwann cell microtubule cytoskeleton. Hum Mol Genet., 16(14), 
1742-1751. 
Nanney, D. L., and McCoy, J.W. Characterization of the Species of the Tetrahymena 
pyriformis Complex. Transactions of the American Microscopical Society, 95(4) 
664-682 
Narasimhulu, S. B. (1998). Characterization of microtubule binding domains in the 
Arabidopsis kinesin-like calmodulin binding protein. The Plant Cell, 10(6), 957-966.  
Niggli V, Andreoli C, Roy C, Mangeat P. 1995.  Identification of a phosphatidylinositol-
4,5-bisphosphate-binding domain in the N-terminal region of ezrin. FEBS Lett., 
376, 172-176. 
Nilsson, J.R., Van Deurs, B. (1983). Coated pits and pinocytosis in Tetrahymena. J Cell 
Sci. 63, 209– 222 
Ng S.F., (1978). Directionality of microtubule assembly: an in vivo study with the ciliate 
Tetrahymena. J Cell Sci 33(1), 227-234  
Numata O., Fujiu K., and Gonda K. (1999). Macronuclear division and cytokinesis in 
Tetrahymena. Cell Biology International, 23(12), 849-857.  
Odronitz F. and Kollmar M. (2007). Drawing the tree of eukaryotic life based on the 
analysis of 2,260 manually annotated myosins from 328 species. Genome 
Biology, 8 (9). 10.1186/gb-2007-8-9-r196 
 102 
 Orias, E. (1991). On the evolution of the karyorelict ciliate life cycle: Heterophasic 
ciliates and the origin of ciliate binary fission. Bio Systems, 25(1-2), 67-73.  
Orias E. Flacks M. 1975.  Macronuclear genetics of Tetrahymena. I. Random distribution 
of macronuclear genecopies in Tetrahymena pyriformis syngen 1.  Genetics, 79, 
187-206. 
Orias E, Hamilton EP, Orias J.  2000.  Tetrahymena as a laboratory organism: Useful 
strains, cell culture, and cell line maintenance. In: Asai DJ, Forney JD, editors. 
Methods in Cell Biology: Tetrahymena thermophila. New York: Academic Press 
62: 189-211. 
Percipalle P, Fomproix N, Cavellán E, Voit R, Reimer G, Krüger T, Thyberg J, Scheer U, 
Grummt I, Farrants AK. 2006. The chromatin remodelling complex WSTF-
SNF2h interacts with nuclear myosin 1 and has a role in RNA polymerase I 
transcription. EMBO Rep. 5:525-30 
Pearson M.A., Reczek D., Bretscher A., and Karplus P.A. (2000). Structure of the ERM 
protein moesin reveals the FERM domain fold masked by an extended actin 
binding tail domain. Cell., 101(3), 259-270 
Pérez-Ferreiro, C. M. (2006). Protein 4.1R self-association: Identification of the binding 
domain. The Biochemical Journal, 400(3), 457.  
Philimonenko VV, Janácek J, Harata M, Hozák P. (2010). Transcription-dependent 
rearrangements of actin and nuclear myosin I in the nucleolus. Histochem Cell 
Biol. 134(3):243-9 
Pollard, T. D., and Korn, E. D. (1973). Acanthamoeba myosin. I. Isolation from 
Acanthamoeba castellanii of an enzyme similar to muscle. Journal of Biological 
Chemistry, 248(13), 4682-4690.  
Pollenz, R. S. (1992). The dictyostelium essential light chain is required for myosin 
function. Cell, 69(6), 951-962. 
Pranchevicius MC, Baqui MM, Ishikawa-Ankerhold HC, Lourenço EV, Leão RM, Banzi 
SR, dos Santos CT, Roque-Barreira MC, Espreafico EM, Larson RE. (2008). 
Myosin Va phosphorylated on Ser1650 is found in nuclear speckles and 
redistributes to nucleoli upon inhibition of transcription. CMC. 65(6): 441-56.  
 
 103 
  
Rannestad J., and Williams N.E., The synthesis of microtubules and other proteins of the 
oral apparatus in Tetrahymena pyriformis. JCB 50, 709-720,  
Rahaman A, Elde NC, Turkewitz AP.  2008.  A dynamin-related protein required for 
nuclear remodeling in Tetrahymena. Curr Biol., 18, 1227-1233. 
Rasmussen, L., and Orias, E. (1975). Tetrahymena: Growth Without Phagocytosis. 
Science, 190(4213), 464-465. 
Rhoads, A.R., Friedberg, F. (1997). Sequence motifs for calmodulin recognition. The 
FASEB Journal, 11(5), 331-340.  
Richards, T.A. and Cavalier-Smith, T. (2005). Myosin domain evolution and the primary 
divergence of eukaryotes. Nature, 436(7054), 1113-1118.  
Reddy, V.S., and Reddy A.S., (1999). A plant calmodulin-binding motor is part kinesin 
and part myosin. Bioinformatics, 15(12), 1055-1057.  
Saitoh A, Takiguchi K, Tanaka Y, Hotani H. 1998. Opening-up of liposomal membranes 
by talin.  Proc Natl Acad Sci USA 95, 1026-1031.  
Salerno VP, Calliari A, Provance DW Jr, Sotelo-Silveira JR, Sotelo JR, Mercer JA. 
(2008). Myosin-Va mediates RNA distribution in primary fibroblasts from 
multiple organs. CMC. 65(5):422-33. 
Sandquist, J.C., Bement, W., (2010). Characterizing the Role of Myosin-10 in Regulating 
Mitotic Spindle Structure and Function. Mol. Biol. Cell 21 (suppl), Abstract B 
1263. 
Sandquist, J.C., Woolner, s., Bement, W., (2009). Characterization of a Novel Interaction 
between Myosin-10 and a Mitotic Kinase. Mol. Biol. Cell 20 (suppl), Abstract B 
513. 
Shearer, A.E., Hildebrand, M.S., Webster, J.A., Kahrizi, K., Meyer, N.C., Jalalvand, K., 
Arzhanginy, S.,Kimberling, W.J., Stephan, D., Bahlo, M., Smith, R.J. and 
Najmabadi, H. 2009. Mutations in the first MyTH4 domain of MYO15A are a 
common cause of DFNB3 hearing loss. Laryngoscope 119, 727-733. 
Stattilaro R.F., Dentler W.L., and LeCluyse E.L. (1981). Microtubule-associated proteins 
(MAPs) and the organization of actin filaments in vitro. JCB, (90), 467-473. 
 104 
Schwander M, Lopes V, Sczaniecka A, Gibbs D, Lillo C, Delano D, Tarantino LM, 
Wiltshire T, Williams DS, Müller U. (2009). A novel allele of myosin VIIa 
reveals a critical function for the C-terminal FERM domain for melanosome 
transport in retinal pigment epithelial cells. J Neurosci. 29(50):15810-8. 
Straub, F.B. (1942). Actin. Stud. Inst. Med. Chem. Univ. Szeged. II:3–15. 
Straub, F.B. (1943). Actin, II. Stud. Inst. Med. Chem. Univ. Szeged. III:23–37. 
Shang, Y., Song, X., Bowen, J., Corstanje, R., Gao, Y., Gaertig, J., Gorovsky M.A. 
(2002). A robust inducible-repressible promoter greatly facilitates gene 
knockouts, conditional expression, and overexpression of homologous and 
heterologous genes in Tetrahymena thermophila. PNAS, 99(6), 3734-3739.  
Shimizu T., Seto A., Maita N., Hamada K., Tsukita S., Tsukita S., and Hakoshima T. 
(2002). Structural basis for neurofibromatosis type 2. Crystal structure of the 
merlin FERM domain. J Biol Chem. 277(12):10332-10336 
Smith JS, Yakisich JS, Kapler GM, Cole ES, Romero P. 2004. A ß-Tubulin mutation 
selectively uncouples nuclear division and cytokinesis in Tetrahymena 
thermophila. Eukaryot. Cell, 3, 1217-1226. 
Spudich J.A., Lin S., (1973). Cytochalasin B, Its Interaction with Actin and Actomyosin 
from Muscle. Proc Natl Acad Sci., 9(2), 442–446. 
Stuart KS, Cole, ES 2000. Nuclear and cytoskeletal fluorescence microscopy techniques. 
In: Asai, DJ, Forney JD, editors. Methods in Cell Biology: Tetrahymena 
thermophila. New York: Academic Press 62: 291-311. 
Sugita, M., Nakano, K., Sato, M., Toyooka, K. and Numata, O. (2009) The roles of actin 
cytoskeleton and microtubules for membrane recycling of a food vacuole in 
Tetrahymena thermophila. Cell Motil Cytoskeleton, 66: 371-377. 
Takeda S, Saitoh A, Furuta M, Satomi N, Ishino A, Nishida G, Sudo H, Hotani H, 
Takiguchi K.  2006.  Opening of holes in liposomal membranes is induced by 
proteins possessing the FERM domain. J Mol Biol. 362:403-413 
Titus MA. 2003. An unconventional myosin essential for the initiation of Dictyostelium 
development. Mol Biol Cell 14:S, 181a. 
 105 
Todi, S.V., Sivan-Loukianova, E., Jacobs J.S., Kiehart, D.P., and Eberl, D.F. (2008). 
Myosin VIIA, important for human auditory function, is necessary for drosophila 
auditory organ development. PloS One, 3(5) :e2115. 
Tondravi M.M., and Yao M.C., (1986). Transformation of Tetrahymena thermophila by 
microinjection of ribosomal RNA genes. PNAS 83, 4369-4373.  
Tuxworth, R. I., Stephens, S., Ryan, Z. C., and Titus, M. A. (2005). Identification of a 
myosin VII-talin complex. Journal of Biological Chemistry, 280(28), 26557-
26564.  
Wang A, Liang Y, Fridell RA, Probst FJ, Wilcox ER, Touchman JW, Morton CC, Morell 
RJ, Noben-Trauth K, Camper SA, Friedman TB.1998. Association of 
unconventional myosin MYO15 mutations with human nonsyndromic deafness 
DFNB3. Science, 280, 1447-1451. 
Weber, K. L. (2004). A microtubule-binding myosin required for nuclear anchoring and 
spindle assembly. Nature, 431(7006), 325-329.  
Weil D, Blanchard S, Kaplan J, Guilford P, Gibson F, Walsh J, Mburu P, Varela A, 
Levilliers J, Weston MD, et al. 1995. Defective myosin VIIA gene responsible for 
Usher syndrome type 1B. Nature, 374, 60-61. 
Williams NE. 2000. Immunoprecipitation Procedures. In: Asai DJ, Forney JD, editors. 
Methods in Cell Biology: Tetrahymena thermophila. New York: Academic Press 
62:449-453 
Williams, N., and Williams, R. (1976). Macronuclear division with and without 
microtubules in tetrahymena. Journal of Cell Science, 20(1), 61-77.  
Williams, N.E., Tsao, C.C., Bowen, J., Hehman, G.L., Williams R.J., and Frankel J. 
(2006). The Actin Gene ACT1 Is Required for Phagocytosis, Motility, and Cell 
Separation of Tetrahymena thermophila. Eukaryotic Cell 5(3), 555-567. 
Williams, S. A., Hosein R.E. and Gavin R.H. (2000). MYO1, a novel, unconventional 
myosin gene affects endocytosis and macronuclear elongation in tetrahymena 
thermophila. The Journal of Eukaryotic Microbiology, 47(6), 561-568.  
Williams, S. A., and Gavin, R.H. (2005). Myosin genes in tetrahymena. Cell Motility and 
the Cytoskeleton, 61(4), 237-243.  
 106 
Wloga D, Rogowski K, Sharma N, Van Dijk J, Janke C, Eddé B, Bré MH, Levilliers N, 
Redeker V, Duan J, Gorovsky MA, Jerka-Dziadosz M, Gaertig J.  2008.  
Glutamylation on alpha-tubulin is not essential but affects the assembly and 
functions of a subset of microtubules in Tetrahymena thermophila. Eukaryot Cell 
7, 1362-1372. 
Wolfrum, U., Liu, X., Schmitt, A., Udovichenko, I.P., Williams, D.S. (1998). Myosin 
VIIa as a common component of cilia and microvilli. Cell Motility and the 
Cytoskeleton, 40(3), 261-271.  
Woods G., and Zito K. (2008). Preparation of Gene Gun Bullets and Biolistic 
Transfection of Neurons in Slice Culture. JoVE. 12. 
http://www.jove.com/index/Details.stp?ID=675, doi: 10.3791/675  
Xu, H. and Gutman, D. H. (1998) Merlin differentially associates with the microtubule 
  and actin cytoskeleton. J. Neurosci. Res. 51, 403–415 
Xu, P., Mitchelhill, K. I., Kobe, B., Kemp, B. E., and Zot, H. G. (1997). The myosin-I 
 binding protein Acan125 binds the SH3 domain and belongs to the superfamily 
 of leucine-rich repeat proteins. PNAS, 94(8), 3685-3690.  
Yan, B., Calderwood, D. A., Yaspan, B., and Ginsberg, M. H. (2001). Calpain cleavage 
promotes talin binding to the beta 3 integrin cytoplasmic domain. Journal of 
Biological Chemistry, 276(30), 28164-28170.  
Yang Y, Baboolal TG, Siththanandan V, Chen M, Walker ML, Knight PJ, Peckham M, 
Sellers JR.  2009. A FERM domain autoregulates Drosophila myosin 7a activity. 
Proc Natl Acad Sci USA 106, 4189-4194. 
Yao, M. C. (1986). Amplification of Ribosomal RNA genes. In: Gall, L. G. (ed.), The 
 Molecular Biology of Ciliated Protozoa. Academic Press, Orlando. p. 179-201. 
Yonezawa, S., Yoshizaki, N., Sano, M., Hanai, A., Masaki, S., Takizawa, T., Kageyama, 
T., Moriyama, A. (2003). Possible involvement of myosin-X in intercellular 
adhesion: Importance of serial pleckstrin homology regions for intracellular 
localization. Development, Growth Differentiation, 45(2), 175-185.  
 107 
Yumura, S., and  Uyeda, T.Q. (1997). Transport of myosin II to the equatorial region 
without its own motor activity in mitotic Dictyostelium cells. Molecular Biology of 
the Cell, 8(10), 20890-2099.  
Zaug, A., and Cech, T. (1986). The intervening sequence RNA of tetrahymena is an 
enzyme. Science, 231(4737), 470-475.  
Zhang H, Berg JS, Li Z, Wang Y, Lang P, Sousa AD, Bhaskar A, Cheney RE, Stromblad 
S.  2004.  Myosin-X provides a motor-based link between integrins and the 
cytoskeleton. Nat Cell Biol., 6, 523-531. 
